VALIDATION REPORT (PHASE 2) FOR THE FISH SEXUAL DEVELOPMENT TEST FOR THE DETECTION OF ENDOCRINE ACTIVE SUBSTANCES by Holbech, Henrik et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unclassified ENV/JM/MONO(2011)23
  
Organisation de Coopération et de Développement Économiques   
Organisation for Economic Co-operation and Development  29-Jul-2011 
___________________________________________________________________________________________
English - Or. English 
ENVIRONMENT DIRECTORATE 
JOINT MEETING OF THE CHEMICALS COMMITTEE AND 
THE WORKING PARTY ON CHEMICALS, PESTICIDES AND BIOTECHNOLOGY 
 
 
 
  
 
 
VALIDATION REPORT (PHASE 2) FOR THE FISH SEXUAL DEVELOPMENT TEST FOR THE 
DETECTION OF ENDOCRINE ACTIVE SUBSTANCES 
 
Series on Testing and Assessment 
 
No. 142 
 
 
 
 
 
 
 
 
 
 
JT03305646 
 
Document complet disponible sur OLIS dans son format d'origine 
Complete document available on OLIS in its original format 
 
EN
V
/JM
/M
O
N
O
(2011)23 
U
nclassified 
English - O
r. English
 
 
ENV/JM/MONO(2011)23 
 2
ENV/JM/MONO(2011)23 
  
 3
 
OECD Environment, Health and Safety Publications 
 
Series on Testing and Assessment 
 
 
No. 142 
 
 
 VALIDATION REPORT (PHASE 2) FOR THE FISH SEXUAL DEVELOPMENT TEST FOR 
THE DETECTION OF ENDOCRINE ACTIVE SUBSTANCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Environment Directorate 
ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT 
Paris 2011 
ENV/JM/MONO(2011)23 
 
 4
Also published in the Series on Testing and Assessment: 
 
No. 1,  Guidance Document for the Development of OECD 
Guidelines for Testing of Chemicals (1993; reformatted 1995, revised 
2006) 
No. 2,  Detailed Review Paper on Biodegradability Testing (1995) 
No. 3,  Guidance Document for Aquatic Effects Assessment (1995) 
No. 4,  Report of the OECD Workshop on Environmental 
Hazard/Risk Assessment (1995) 
No. 5,  Report of the SETAC/OECD Workshop on Avian Toxicity 
Testing (1996) 
No. 6,  Report of the Final Ring-test of the Daphnia magna 
Reproduction Test (1997) 
No. 7,  Guidance Document on Direct Phototransformation of 
Chemicals in Water (1997) 
No. 8,  Report of the OECD Workshop on Sharing Information 
about New Industrial Chemicals Assessment (1997) 
No. 9,  Guidance Document for the Conduct of Studies of 
Occupational Exposure to Pesticides during Agricultural Application 
(1997) 
No. 10,  Report of the OECD Workshop on Statistical Analysis of 
Aquatic Toxicity Data (1998) 
No. 11,  Detailed Review Paper on Aquatic Testing Methods for 
Pesticides and industrial Chemicals (1998) 
No. 12,  Detailed Review Document on Classification Systems for 
Germ Cell Mutagenicity in OECD Member Countries (1998) 
No. 13,  Detailed Review Document on Classification Systems for 
Sensitising Substances in OECD Member Countries 1998) 
No. 14,  Detailed Review Document on Classification Systems for 
Eye Irritation/Corrosion in OECD Member Countries (1998) 
No. 15,  Detailed Review Document on Classification Systems for 
Reproductive Toxicity in OECD Member Countries (1998) 
No. 16,  Detailed Review Document on Classification Systems for 
Skin Irritation/Corrosion in OECD Member Countries (1998) 
ENV/JM/MONO(2011)23 
  
 5
No. 17,  Environmental Exposure Assessment Strategies for Existing 
Industrial Chemicals in OECD Member Countries (1999) 
No. 18,  Report of the OECD Workshop on Improving the Use of 
Monitoring Data in the Exposure Assessment of Industrial Chemicals 
(2000) 
No. 19,  Guidance Document on the Recognition, Assessment and 
Use of Clinical Signs as Humane Endpoints for Experimental Animals 
used in Safety Evaluation (1999) 
No. 20,  Revised Draft Guidance Document for Neurotoxicity 
Testing (2004) 
No. 21,  Detailed Review Paper: Appraisal of Test Methods for Sex 
Hormone Disrupting Chemicals (2000) 
No. 22,  Guidance Document for the Performance of Out-door 
Monolith Lysimeter Studies (2000) 
No. 23,  Guidance Document on Aquatic Toxicity Testing of Difficult 
Substances and Mixtures (2000) 
No. 24,  Guidance Document on Acute Oral Toxicity Testing (2001) 
No. 25,  Detailed Review Document on Hazard Classification 
Systems for Specifics Target Organ Systemic Toxicity Repeated 
Exposure in OECD Member Countries (2001) 
No. 26,  Revised Analysis of Responses Received from Member 
Countries to the Questionnaire on Regulatory Acute Toxicity Data 
Needs (2001) 
No 27,  Guidance Document on the Use of the Harmonised System 
for the Classification of Chemicals which are Hazardous for the 
Aquatic Environment (2001) 
No 28,  Guidance Document for the Conduct of Skin Absorption 
Studies (2004) 
No 29,  Guidance Document on Transformation/Dissolution of 
Metals and Metal Compounds in Aqueous Media (2001) 
No 30,  Detailed Review Document on Hazard Classification 
Systems for Mixtures (2001) 
No 31,  Detailed Review Paper on Non-Genotoxic Carcinogens 
Detection: The Performance of In-Vitro Cell Transformation Assays 
(2007)  
No. 32,  Guidance Notes for Analysis and Evaluation of Repeat-
Dose Toxicity Studies (2000) 
ENV/JM/MONO(2011)23 
 
 6
No. 33,  Harmonised Integrated Classification System for Human 
Health and Environmental Hazards of Chemical Substances and 
Mixtures (2001) 
No. 34,  Guidance Document on the Development, Validation and 
Regulatory Acceptance of New and Updated Internationally Acceptable 
Test Methods in Hazard Assessment (2005) 
No. 35,  Guidance notes for analysis and evaluation of chronic 
toxicity and carcinogenicity studies (2002) 
No. 36,  Report of the OECD/UNEP Workshop on the use of 
Multimedia Models for estimating overall Environmental Persistence 
and long range Transport in the context of PBTS/POPS Assessment 
(2002) 
No. 37,  Detailed Review Document on Classification Systems for 
Substances Which Pose an Aspiration Hazard (2002) 
No. 38,  Detailed Background Review of the Uterotrophic Assay 
Summary of the Available Literature in Support of the Project of the 
OECD Task Force on Endocrine Disrupters Testing and Assessment 
(EDTA) to Standardise and Validate the Uterotrophic Assay (2003) 
No. 39,  Guidance Document on Acute Inhalation Toxicity Testing 
(in preparation) 
No. 40,  Detailed Review Document on Classification in OECD 
Member Countries of Substances and Mixtures Which Cause 
Respiratory Tract Irritation and Corrosion (2003) 
No. 41,  Detailed Review Document on Classification in OECD 
Member Countries of Substances and Mixtures which in Contact with 
Water Release Toxic Gases (2003) 
No. 42,  Guidance Document on Reporting Summary Information on 
Environmental, Occupational and Consumer Exposure (2003) 
No. 43,  Guidance Document on Mammalian Reproductive Toxicity 
Testing and Assessment (2008) 
No. 44,  Description of Selected Key Generic Terms Used in 
Chemical Hazard/Risk Assessment (2003) 
 
No. 45,  Guidance Document on the Use of Multimedia Models for 
Estimating Overall Environmental Persistence and Long-range 
Transport (2004) 
No. 46,  Detailed Review Paper on Amphibian Metamorphosis 
Assay for the Detection of Thyroid Active Substances (2004) 
ENV/JM/MONO(2011)23 
  
 7
No. 47,  Detailed Review Paper on Fish Screening Assays for the 
Detection of Endocrine Active Substances (2004) 
No. 48,  New Chemical Assessment Comparisons and Implications 
for Work Sharing (2004) 
No. 49,  Report from the Expert Group on (Quantitative) Structure-
Activity Relationships [(Q)SARs] on the Principles for the Validation of 
(Q)SARs (2004)  
No. 50,  Report of the OECD/IPCS Workshop on Toxicogenomics 
(2005)  
No. 51,  Approaches to Exposure Assessment in OECD Member 
Countries: Report from the Policy Dialogue on Exposure Assessment in 
June 2005 (2006) 
No. 52,  Comparison of emission estimation methods used in 
Pollutant Release and Transfer Registers (PRTRs) and Emission 
Scenario Documents (ESDs): Case study of pulp and paper and textile 
sectors (2006) 
No. 53,  Guidance Document on Simulated Freshwater Lentic Field 
Tests (Outdoor Microcosms and Mesocosms) (2006) 
No. 54,  Current Approaches in the Statistical Analysis of 
Ecotoxicity Data: A Guidance to Application (2006) 
No. 55,  Detailed Review Paper on Aquatic Arthropods in Life Cycle 
Toxicity Tests with an Emphasis on Developmental, Reproductive and 
Endocrine Disruptive Effects (2006) 
No. 56,  Guidance Document on the Breakdown of Organic Matter 
in Litter Bags (2006) 
No. 57,  Detailed Review Paper on Thyroid Hormone Disruption 
Assays (2006) 
No. 58,  Report on the Regulatory Uses and Applications in OECD 
Member Countries of (Quantitative) Structure-Activity Relationship 
[(Q)SAR] Models in the Assessment of New and Existing Chemicals 
(2006)  
No. 59,  Report of the Validation of the Updated Test Guideline 407: 
Repeat Dose 28-Day Oral Toxicity Study in Laboratory Rats (2006) 
No. 60,  Report of the Initial Work Towards the Validation of the 21-
Day Fish Screening Assay for the Detection of Endocrine Active 
Substances (Phase 1A) (2006) 
ENV/JM/MONO(2011)23 
 
 8
No. 61,  Report of the Validation of the 21-Day Fish Screening 
Assay for the Detection of Endocrine Active Substances (Phase 1B) 
(2006) 
No. 62,  Final OECD Report of the Initial Work Towards the 
Validation of the Rat Hershberger Assay: Phase-1, Androgenic 
Response to Testosterone Propionate, and Anti-Androgenic Effects of 
Flutamide (2006) 
No. 63,  Guidance Document on the Definition of Residue (2006) 
No. 64,  Guidance Document on Overview of Residue Chemistry 
Studies (2006) 
No. 65,  OECD Report of the Initial Work Towards the Validation of 
the Rodent Uterotrophic Assay - Phase 1 (2006) 
No. 66,  OECD Report of the Validation of the Rodent Uterotrophic 
Bioassay: Phase 2. Testing of Potent and Weak Oestrogen Agonists by 
Multiple Laboratories (2006) 
No. 67,  Additional data supporting the Test Guideline on the 
Uterotrophic Bioassay in rodents (2007) 
No. 68,  Summary Report of the Uterotrophic Bioassay Peer Review 
Panel, including Agreement of the Working Group of the National 
Coordinators of the Test Guidelines Programme on the follow up of 
this report (2006) 
No. 69,  Guidance Document on the Validation of (Quantitative) 
Structure-Activity Relationship [(Q)SAR] Models (2007) 
No. 70,  Report on the Preparation of GHS Implementation by the 
OECD Countries (2007)  
No. 71,  Guidance Document on the Uterotrophic Bioassay - 
Procedure to Test for Antioestrogenicity (2007)  
No. 72,  Guidance Document on Pesticide Residue Analytical 
Methods (2007) 
No. 73,  Report of the Validation of the Rat Hershberger Assay: 
Phase 3: Coded Testing of Androgen Agonists, Androgen Antagonists 
and Negative Reference Chemicals by Multiple Laboratories. Surgical 
Castrate Model Protocol (2007)  
No. 74,  Detailed Review Paper for Avian Two-generation Toxicity 
Testing (2007)  
No. 75,  Guidance Document on the Honey Bee (Apis Mellifera L.) 
Brood test Under Semi-field Conditions (2007) 
ENV/JM/MONO(2011)23 
  
 9
No. 76,  Final Report of the Validation of the Amphibian 
Metamorphosis Assay for the Detection of Thyroid Active Substances: 
Phase 1 - Optimisation of the Test Protocol (2007) 
No. 77,  Final Report of the Validation of the Amphibian 
Metamorphosis Assay: Phase 2 - Multi-chemical Interlaboratory Study 
(2007) 
No. 78,  Final Report of the Validation of the 21-day Fish Screening 
Assay for the Detection of Endocrine Active Substances. Phase 2: 
Testing Negative Substances (2007) 
No. 79,  Validation Report of the Full Life-cycle Test with the 
Harpacticoid Copepods Nitocra Spinipes and Amphiascus Tenuiremis 
and the Calanoid Copepod Acartia Tonsa - Phase 1 (2007) 
No. 80,  Guidance on Grouping of Chemicals (2007) 
No. 81,  Summary Report of the Validation Peer Review for the 
Updated Test Guideline 407, and Agreement of the Working Group of 
National Coordinators of the Test Guidelines Programme on the 
follow-up of this report (2007)  
No. 82,  Guidance Document on Amphibian Thyroid Histology 
(2007) 
No. 83,  Summary Report of the Peer Review Panel on the Stably 
Transfected Transcriptional Activation Assay for Detecting Estrogenic 
Activity of Chemicals, and Agreement of the Working Group of the 
National Coordinators of the Test Guidelines Programme on the 
Follow-up of this Report (2007) 
No. 84,  Report on the Workshop on the Application of the GHS 
Classification Criteria to HPV Chemicals, 5-6 July Bern Switzerland 
(2007) 
No. 85,  Report of the Validation Peer Review for the Hershberger 
Bioassay, and Agreement of the Working Group of the National 
Coordinators of the Test Guidelines Programme on the Follow-up of 
this Report (2007) 
No. 86,  Report of the OECD Validation of the Rodent Hershberger 
Bioassay:  Phase 2: Testing of Androgen Agonists, Androgen 
Antagonists and a 5 α-Reductase Inhibitor in Dose Response Studies by 
Multiple Laboratories (2008)  
No. 87,  Report of the Ring Test and Statistical Analysis of 
Performance of the Guidance on Transformation/Dissolution of Metals 
and Metal Compounds in Aqueous Media (Transformation/ Dissolution 
Protocol) (2008) 
ENV/JM/MONO(2011)23 
 
 10
No.88,  Workshop on Integrated Approaches to Testing and 
Assessment (2008) 
No.89,  Retrospective Performance Assessment of the Test 
Guideline 426 on Developmental Neurotoxicity (2008) 
No.90,  Background Review Document on the Rodent Hershberger 
Bioassay (2008) 
No.91,  Report of the Validation of the Amphibian Metamorphosis 
Assay (Phase 3) (2008) 
No.92,  Report of the Validation Peer Review for the Amphibian 
Metamorphosis Assay and Agreement of the Working Group of the 
National Coordinators of the Test Guidelines Programme on the 
Follow-Up of this Report (2008) 
No.93,  Report of the Validation of an Enhancement of OECD TG 
211: Daphnia Magna Reproduction Test (2008) 
No.94,  Report of the Validation Peer Review for the 21-Day Fish 
Endocrine Screening Assay and Agreement of the Working Group of 
the National Coordinators of the Test Guidelines Programme on the 
Follow-up of this Report (2008) 
No.95,  Detailed Review Paper on Fish Life-Cycle Tests (2008) 
No.96,  Guidance Document on Magnitude of Pesticide Residues in 
Processed Commodities (2008) 
No.97,  Detailed Review Paper on the use of Metabolising Systems 
for In Vitro Testing of Endocrine Disruptors (2008) 
No. 98,  Considerations Regarding Applicability of the Guidance on 
Transformation/Dissolution of Metals Compounds in Aqueous Media 
(Transformation/Dissolution Protocol) (2008) 
No. 99,  Comparison between OECD Test Guidelines and ISO 
Standards in the Areas of Ecotoxicology and Health Effects (2008) 
No.100, Report of the Second Survey on Available Omics Tools  
(2009) 
No.101, Report of the Workshop on Structural Alerts for the OECD 
(Q)SAR Application Toolbox, 15-16 May 2008, Utrecht, the 
Netherlands  (2009) 
No. 102, Guidance Document for using the OECD (Q)SAR 
Application Toolbox to Develop Chemical Categories According to the 
OECD Guidance on Grouping of Chemicals (2009) 
ENV/JM/MONO(2011)23 
  
 11
No. 103, Detailed Review Paper on Transgenic Rodent Mutation 
Assays (2009) 
No. 104, Performance Assessment: Conparsion of 403 and CxT 
Protocols via Simulation and for Selected Real Data Sets (2009) 
No. 105, Report on Biostatistical Performance Assessment of the 
draft TG 436 Acute Toxic Class Testing Method for Acute Inhalation 
Toxicity (2009) 
No. 106, Guidance Document for Histologic Evaluation of Endocrine 
and Reproductive Test in Rodents (2009) 
No. 107, Preservative treated wood to the environment for wood held 
in storage after treatment and for wooden commodities that are not 
cover and are not in contact with ground. (2009) 
No. 108, Report of the validation of the Hershberger Bioassay 
(weanling model) (2009) 
No. 109, Literature review on the 21-Day Fish Assay and the Fish 
Short-Term Reproduction Assay (2009) 
No. 110, Report of the validation peer review for the weanling 
Hershberger Bioassay and agreement of the working of national 
coordinators of the test guidelines programme on the follow-up of this 
report (2009) 
No. 111, Report of the Expert Consultation to Evaluate an Estrogen 
Receptor Binding Affinity Model for Hazard Identification (2009) 
No. 112, The 2007 OECD List of High Production Volume Chemicals 
(2009) 
No. 113, Report of The Focus Session on Current and Forthcoming 
Approaches for Chemical Safety and Animal Welfare (2010) 
No. 114, Performance Assessment of Different Cytotoxic and 
Cytostatic Measures for the In Vitro Micronucleus Test (MNVIT): 
Summary of results in the collaborative trial (2010) 
No. 115, Guidance Document on the Weanling Hershberger Bioassay 
in Rats: A Short-term Screening Assay for (Anti) Androgenic Properties 
(2009) 
No. 116, Guidance Document on the Design and Conduct of Chronic 
Toxicity and Carcinogenicity Studies, Supporting TG 451, 452 and 453 
(2010)  
No. 117, Guidance Document 117 on the Current Implementation of 
Internal Triggers in Test Guideline 443 for an Extended One 
ENV/JM/MONO(2011)23 
 
 12
Generation Reproductive Toxicity Study, in the United States and 
Canada (2011) 
No. 118, Workshop Report on OECD Countries Activities Regarding 
Testing, Assessment and Management of Endocrine Disrupters Part I 
and Part II (2010) 
No. 119, Classification and Labelling of chemicals according to the 
UN Globally Harmonized System: Outcome of the Analysis of 
Classification of Selected Chemicals listed in Annex III of the 
Rotterdam Convention (2010) 
No. 120, Part 1:  Report of the Expert Consultation on Scientific and 
Regulatory Evaluation of Organic Chemistry Mechanism-based 
Structural Alerts for the Identification of DNA Binding Chemicals 
No. 120, Part 2: Report of the Expert Consultation on Scientific and 
Regulatory Evaluation of Organic Chemistry Mechanism-based 
Structural Alerts for the Identification of DNA Binding Chemicals 
 No. 121, Detailed review paper (DRP) on Molluscs life-cycle Toxicity 
Testing (2010) 
No. 122, Guidance Document on the determination of the Toxicity of 
a Test Chemical to the Dung Beetle Aphodius Constans (2010)   
No. 123, Guidance Document on the Diagnosis of Endocrine-related 
Histopathology in Fish Gonads (2010) 
No. 124, Guidance for the Derivation of an Acute Reference Dose 
(2010) 
No. 125, Guidance Document on Histopathology for Inhalation 
Toxicity Studies, Supporting TG 412 (Subacute Inhalation Toxicity: 28-
Day) and TG 413 (Subchronic Inhalation Toxicity: 90-Day) (2010) 
No. 126, Short Guidance on the Threshold approach for Acute Fish 
Toxicity (2010) 
No. 127, Peer review report of the validation of the 21-day 
androgenised female stickleback screening assay (2010) 
No. 128, Validation Report of the 21-day Androgenised Female 
Stickleback Screening Assay (2010) 
 
No. 129, Guidance Document on using Cytotoxicity Tests to 
Estimate Starting Doses for Acute Oral Systemic Toxicity Tests 
 
No. 131, Report of the Test Method Validation of Avian Acute Oral 
Toxicity Test (OECD test guideline 223) (2010) 
 
ENV/JM/MONO(2011)23 
  
 13
 No.132, Report of the Multi-Laboratory Validation of the H295R 
Steroidogenesis Assay to Identify Modulators (2010) 
 
No.133, Peer Review Report for the H295R Cell-Based Assay for 
Steroidogenesis (2010) 
 
No.134, Report of the Validation of a Soil Bioaccumulation Test with 
Terrestrial Oligochaetes by an International ring test (2010) 
 
No.135, Detailed Review Paper on Environmental Endocrine 
Disruptor Screening: The use of Estrogen and Androgen Receptor 
Binding and Transactivation Assays in Fish (2010) 
 
No. 136, Validation Report of The Chironomid Full Life-Cycle 
Toxicity Test (2010) 
 
No.137, Explanatory Background Document to the OECD  Test 
Guideline On In Vitro Skin Irritation Testing (2010) 
 
No.138, Report of the Workshop on Using Mechanistic Information 
in Forming Chemical Categories (2011)  
 
No.139, Report of the Expert Consultation on Scientific and 
Regulatory Evaluation of Organic Chemistry Mechanism Based 
Structural Alerts for the Identification of Protein-binding Chemicals 
(2011) 
 
No.140, Report of the WHO/OECD/ILSI (Hesi) Workshop on Risk 
Assessment of Combined Exposures to Multiple Chemicals (2011)  
 
No.141, Validation Report (Phase 1) for the Fish Sexual 
Development Test for the Detection of Endocrine Active Substances 
(2011) 
 
No.142, Validation Report (Phase 2) for the Fish Sexual 
Development Test for the Detection of Endocrine Active Substances 
(2011) 
 
No.143, Peer Review Report for the Validation of the Fish Sexual 
Development Test and Agreement of the Working Group of National 
Co-ordinators of the Test Guideline Programme on the Follow-up of the 
Peer Review (2011)  
 
© OECD 2011 
Applications for permission to reproduce or translate all or part of this 
material should be made to: Head of Publications Service, 
RIGHTS@oecd.org. OECD, 2 rue André-Pascal, 75775 Paris Cedex 
16,France
ENV/JM/MONO(2011)23 
 
 14
 ABOUT THE OECD 
The Organisation for Economic Co-operation and Development (OECD) is an intergovernmental 
organisation in which representatives of 34 industrialised countries in North and South America, Europe 
and the Asia and Pacific region, as well as the European Commission, meet to co-ordinate and harmonise 
policies, discuss issues of mutual concern, and work together to respond to international problems. Most of 
the OECD’s work is carried out by more than 200 specialised committees and working groups composed 
of member country delegates. Observers from several countries with special status at the OECD, and from 
interested international organisations, attend many of the OECD’s workshops and other meetings. 
Committees and working groups are served by the OECD Secretariat, located in Paris, France, which is 
organised into directorates and divisions. 
The Environment, Health and Safety Division publishes free-of-charge documents in ten different series: 
Testing and Assessment; Good Laboratory Practice and Compliance Monitoring; Pesticides and 
Biocides; Risk Management; Harmonisation of Regulatory Oversight in Biotechnology; Safety of 
Novel Foods and Feeds; Chemical Accidents; Pollutant Release and Transfer Registers; Emission 
Scenario Documents; and Safety of Manufactured Nanomaterials. More information about the 
Environment, Health and Safety Programme and EHS publications is available on the OECD’s World 
Wide Web site (www.oecd.org/ehs/). 
 
 
This publication was developed in the IOMC context. The contents do not necessarily reflect the views or 
stated policies of individual IOMC Participating Organisations. 
The Inter-Organisation Programme for the Sound Management of Chemicals (IOMC) was established in 
1995 following recommendations made by the 1992 UN Conference on Environment and Development to 
strengthen co-operation and increase international co-ordination in the field of chemical safety. The 
Participating Organisations are FAO, ILO, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD. 
UNDP is an observer. The purpose of the IOMC is to promote co-ordination of the policies and activities 
pursued by the Participating Organisations, jointly or separately, to achieve the sound management of 
chemicals in relation to human health and the environment. 
  
 
 ENV/JM/MONO(2011)23 
 
 15
 
This publication is available electronically, at no charge. 
 
 
For this and many other Environment, 
Health and Safety publications, consult the OECD’s 
World Wide Web site (www.oecd.org/ehs/) 
 
 
or contact: 
 
 
OECD Environment Directorate, 
Environment, Health and Safety Division 
2 rue André-Pascal 
 75775 Paris Cedex 16 
France 
 
Fax: (33-1) 44 30 61 80 
 
E-mail: ehscont@oecd.org  
 
ENV/JM/MONO(2011)23 
 
 16
 
FOREWORD 
This document presents the validation report (phase 2) of the Fish Sexual Development Test (FSDT). The 
Fish Sexual Development Test (FSDT) covers a life-stage where sexual development is particularly 
sensitive to perturbation caused by endocrine active chemicals. The chemical exposure lasts for about 60 
days, at the end of which endpoints of ecological relevance like the sex ratio of the exposed fish is 
calculated and the biomarker endpoint vitellogenin is measured in individual animals. 
In 2003, Denmark, on behalf of the European Nordic countries, proposed a new project o develop a Test 
Guideline on the fish sexual development test to the Working Group of the National Coordinators of the 
Test Guidelines Programme (WNT). The project was included on the Test Guidelines workplan in 2003, 
and extensive validation of the test method was carried out until 2009. Two validation studies were 
performed, including chemicals representing various modes of action (oestrogen, (anti-)androgen, 
aromatase inhibitor) and negative chemicals. The chemicals tested in the phase 2 validation included the 
weakly active oestrogenic 4-tert-octylphenol and the androgenic dihydrotestosterone for the species 
medaka and zebrafish, and the weakly active oestrogenic 4-tert-pentylphenol, the anti-androgenic 
flutamide and the oestrogenic 17β-estradiol for the stickleback. 
The validation has been overseen by a validation management group for Eco-toxicity testing (VMG-eco) 
and a fish drafting group. A peer-review of the validation has been organised in 2011 and the report is 
available in the Series on Testing and Assessment as No.143. The draft validation report has been endorsed 
by the WNT at its meeting held on 12-14 April 2011. [The Joint Meeting of the Chemicals Committee and 
Working Party on Chemicals, Pesticides and Biotechnology agreed to its declassification on 22 June 2011]. 
This document is published under the responsibility of the Joint Meeting of the Chemicals Committee and 
the Working Party on Chemicals, Pesticides and Biotechnology. 
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EXECUTIVE SUMMARY 
Four small fish species have been exposed to chemicals with different modes of action in two validation 
phases in a total of 29 FSDT experiments including two negative studies (ammonia and n-octanol). The 
tested species are zebrafish, Japanese medaka, fathead minnow and three spined stickleback. Zebrafish has 
been used in 13 experiments, Japanese medaka in seven experiments, three spined stickleback in six 
experiments and finally fathead minnow in three experiments. The weak estrogens 4-tert-pentylphenol and 
4-tert-octylphenol was tested in zebrafish, fathead minnow and medaka, and zebrafish, medaka and 
stickleback respectively. The aromatase inhibiting fungicide prochloraz was tested in zebrafish and fathead 
minnow. The androgen dihydrotestosterone was tested in zebrafish, medaka and stickleback.  
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INTRODUCTION 
1. The need to develop and validate fish assays capable of measuring the effects of endocrine 
disrupting chemicals (or EDCs) originates from concerns that environmental levels of certain chemicals 
may be causing adverse effects in both humans and wildlife due to the interaction of these chemicals with 
the endocrine system. Several cases have been reported where exposures to exogenous chemicals have 
indeed resulted in effects on wildlife, in particular fish [Jensen et al. 2006;Milnes et al. 2006;Orlando et al. 
2004]. In 1997, OECD member countries advised that existing test methods were insufficient to identify 
such substances and characterize their effects. As part of the OECD Test Guidelines Program a Special 
Activity on the Testing and Assessment of Endocrine Disrupters was therefore initiated to revise existing, 
and develop new, OECD Test Guidelines for the screening and testing of potential EDCs.  
2. The Fish Sexual Development Test (FSDT) fits into the OECD Conceptual Framework (CF) for 
the Testing and Assessment of Endocrine Disrupters (EDs) at Level 4 or 5 (the CF is under revision). This 
framework identifies approaches, assays and long-term tests of increasing biological complexity, meant to 
gather information on potential EDCs. Each of the methods added to the framework requires validation to 
ensure its relevance and reliability, its two main pillars. OECD Guidance Document 34 on Validation and 
Acceptance of New and Updated Test Methods for Hazard Assessment [OECD 2005] provides definitions, 
principles and concrete examples of validation, applied in different areas of hazard assessment. The 
validation of the FSDT was conducted to address these principles and is presented in the Phase 1 and Phase 
2 reports. 
3. The FSDT is a modified version of OECD Test Guideline 210 [OECD 1992], the Fish Early-Life 
Stage Toxicity Test with added endpoints for the detection of endocrine disrupters (vitellogenin (VTG) 
measurement and sex ratio). The idea of the assay is that exposure of fish to certain EDs during the 
sensitive window for sexual development will alter the VTG concentration and/or the phenotypic sex. The 
FSDT was initially developed for zebrafish (Danio rerio), which possesses a sensitive window of exposure 
from 20-60 days post hatch (DPH). The window of exposure was chosen to avoid exposure during an 
oversensitive stage, between 10-20 DPH, when high larval mortality can occur [Andersen et al. 2003]. 
After discussion of the test at the OECD in 2003, it was decided that other OECD fish species such as 
Japanese medaka (Oryzias latipes) and fathead minnow (Pimephales promelas), and in 2006 three spined 
stickleback (Gasterosteus aculeatus), should also be tested in the validation exercise. Since the precise 
duration of sexual differentiation and the sensitive window of exposure in species other than zebrafish had 
not been fully explored, the test is started with newly fertilized eggs (instead of larvae) for all species, 
including zebrafish. Chemical exposure was extended until 60 days post hatch, when fish are normally 
sexually differentiated. At the end of the exposure period, animals are terminated and sampled for 
vitellogenin measurement and sex determination via histological examination of the gonads. 
4. During autumn 2005 and early spring 2006 the test proposal was subjected to in-depth statistical 
evaluation, based on existing data from earlier experiments conducted on zebrafish. The first round (Phase 
1) of this validation exercise took place from mid-2006 until mid-2007. Zebrafish (Danio rerio) and 
fathead minnow (Pimephales promelas) were used in the Phase 1. The substances tested were 4-tert-
pentylphenol, an estrogenic chemical, and prochloraz, an aromatase inhibitor. Five European laboratories 
participated in Phase 1 of the validation. Results from Phase 1 are available in a separate report. The 
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outcome of Phase 1 demonstrated that: 1) the fathead minnow sexual differentiation was longer than the 
exposure duration of the test (i.e. 60 days), and 2) the test design allowing an analysis of the variance 
should be preferred over a test design meant to determine an effect concentration (ECx) through a 
regression analysis. Thus for Phas2 of the validation, the fathead minnow was not maintained as a test 
species, but the zebrafish, the Japanese medaka (Oryzias latipes) and the three spined stickleback 
(Gasterosteus aculeatus) were used. The latter two species have the advantage to possess a genetic sex 
marker. Further, the test design used in Phase 2 was standardized with three test concentrations, 4 
replicates per concentration and 40 eggs per replicate at the start of the test. 
5. The second round (Phase 2) of the validation exercise took place from spring 2009 to summer 
2010. The test substances were 4-tert-octylphenol and dihydrotestosterone. Ten laboratories took part in 
Phase 2 of the validation. The results of Phase 2 are reported here. 
SCIENTIFIC RATIONALE FOR THE CORE ENDPOINTS 
Vitellogenin 
6. Vitellogenin (VTG) is a phospholipoglycoprotein precursor to egg yolk protein that normally 
occurs in sexually active females of all oviparous species; the production of VTG is controlled by 
interaction of estrogenic hormones, predominantly 17β-estradiol, with the estrogen receptor [Jobling et al. 
1996]. Males retain the capacity to produce VTG in response to stimulation with estrogen receptor 
agonists; as such, induction of VTG in males has been successfully exploited as a biomarker specific for 
(anti-)estrogenic compounds in a variety of fish species, including fathead minnow, Japanese medaka, 
three spined stickleback and zebrafish. A number of VTG measurement methods have been developed and 
standardized for each of these species [Kunz et al. 2006;Lange et al. 2001;Panter et al. 2002;Panter et al. 
2006;Hahlbeck et al. 2004b]. The criteria for selecting the methods used in this validation program are 
described further in the report. 
Sex ratio 
7. When fish are exposed to EDs during the sensitive window of their sexual development 
(approximately from 0 to 60 days post hatch for the species in the FSDT validation), the phenotypic sex is 
influenced by this chemical exposure. Certain sex-reversed fish may maintain a certain reproductive 
capacity; however, skewed sex ratio in a fish population exposed to EDs can impact its sustainability [Kidd 
et al. 2007]. Phenotypic sex ratio (proportions of males, females etc) is determined via histological 
examination of the gonads. The sex is defined as female, male, intersex or undifferentiated. It is possible to 
determine the genetic sex in some species and this has been done for stickleback and medaka in the present 
validation.   
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OBJECTIVES OF PHASE 2 
8. The objectives of a validation program are to establish that a test method is relevant - meaningful 
for the intended purpose - and reliable – reproducible over time and across laboratories.  
Phase 1 of the validation exercise was the occasion to test two chemicals with different modes of action, an 
estrogen and an aromatase inhibitor, in a limited number of laboratories (n=5), and to demonstrate that the 
test actually works and produces meaningful results. A number of other aspects were also investigated in 
Phase 1, including the test design and two test species, zebrafish (Danio rerio) and fathead minnow 
(Pimephales promelas).  
9. In Phase 2 of the validation, the focus was to investigate the reproducibility of results across 
several participating laboratories using the same fish species, and the same test chemicals at the same 
concentrations. The objective was to have a minimum of three repetitions for each experiment  
[chemical x fish species]. Two chemicals were used: 4-tert-octylphenol, another estrogen, and 
dihydrotestosterone, an androgen. Participating laboratories used zebrafish (LAB 1, LAB 2, LAB 3,  
LAB 4), the medaka (LAB 4, LAB 5, LAB 9 and LAB 10), and the stickleback (LAB 6, LAB 8). LAB 7 
did not submit test results. In most cases, an inter-laboratory comparison of test results was possible. To 
complete the dataset for the stickleback, LAB 6 conducted additional experiments on flutamide and 17ß-
estradiol, and LAB 9 and LAB 10 conducted experiments using 4-tert-pentylphenol, the estrogenic 
chemical used in Phase 1 on zebrafish and fathead minnow, but not yet on medaka. 
10. It is also the purpose of a validation program to understand and define the area of application of 
the test and any limitations to its use. Such limitations are presented in the test results and discussed further 
in the report. Beside the mandatory endpoints, the Kidney Epithelium Hight (KEH) was reported for 
stickleback as an endpoint reflecting the induction of the androgen related protein spiggin. These results 
are not discussed because the method is not validated. The figures are placed in the Appendix.  
ORGANISATION OF PHASE 2 
11. The Danish lead laboratory that coordinated Phase 1 also acted as the lead for Phase 2 of the 
validation. The lead laboratory was responsible for: 
• developing the test protocol, including standard operating procedures and distributing it to the 
participating laboratories; 
• preparing a harmonized template for the collection of test results; 
• centralizing the distribution of test chemicals; 
• collecting all test results; 
• preparing the draft report. 
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12. Phase 2 started in early 2009 and was completed mid-2010. Ten laboratories from Europe and 
Japan took part in the experimental work, as described in Table 1.  
Table 1: Participation in Phase 2, fish species and chemicals tested. 
Participating laboratory Fish species used Chemicals tested 
LAB 1 Zebrafish (ZF) 4-tert-octylphenol, dihydrotestosterone 
LAB 2 Zebrafish (ZF) 4-tert-octylphenol, dihydrotestosterone 
LAB 3 Zebrafish (ZF) dihydrotestosterone 
LAB 4 Zebrafish (ZF) 4-tert-octylphenol 
Medaka (MK) 4-tert-octylphenol 
LAB 5 Medaka (MK) 4-tert-octylphenol, dihydrotestosterone 
LAB 6 Stickleback (STK) 4-tert-octylphenol, dihydrotestosterone, flutamide, 
17beta-estradiol 
LAB 8 Stickleback (STK) 4-tert-octylphenol, dihydrotestosterone 
LAB 9 Medaka (MK) 4-tert-octylphenol, dihydrotestosterone, 4-tert-
pentylphenol 
LAB 10 Medaka (MK) 4-tert-pentylphenol 
Overview of the test protocol 
13. The experimental work was conducted according to the protocol prepared for Phase 2 of the 
validation of the Fish Sexual Development Test for Endocrine Active Substances. A summary of the 
protocol is provided below. 
14. Newly fertilized eggs were exposed, 40 per replicate, 4 replicates per treatment level, three 
treatment levels and appropriate controls (including solvent controls if needed). The chemical exposure 
was flow-through and lasted until 60 days post hatch, the presumed completion of sexual differentiation in 
the following fish species: medaka, stickleback and zebrafish. The protocol was designed to detect the 
effects of EDCs in fish exposed during their sex differentiation period. 
15. Exposure to the test chemical was aqueous, with or without carrier solvent. Monitoring continued 
for up to 60 days post hatch (dph) and included hatching rate, development, survival, growth (total length 
and body weight), sexual differentiation, and VTG concentrations in individual fish.  
Test chemicals and concentrations 
16. The test chemicals and test concentrations were discussed and agreed by the Validation 
Management Group for Ecotoxicity Testing ahead of the study. Dihydrotestosterone is an androgen and 4-
tert-octylphenol is a weak estrogen. Nominal concentrations of the test substances were as follows: 
ENV/JM/MONO(2011)23 
 
 24
• 4-tert-octylphenol: 10, 32 and 100 µg/l (+ water control) for medaka and stickleback Lab 6 
(6.25, 12.5, 25, 50 and 100 µg/l for medaka LAB 9) 
32, 100 and 320 µg/l for stickleback Lab 8 and zebrafish; 
• Dihydrotestosterone: 100, 320 and 1000 ng/l (+ water control). 
Analytical determination of test concentrations 
17. Water samples were collected on a weekly basis in each tank and reported in a spreadsheet. The 
analytical methods used were GC-MS for 4-tert-octylphenol and LC-MSMS or RIA for 
dihydrotestosterone. 
Test acceptability criteria 
18. For the test results to be acceptable, the following conditions applied: 
• The dissolved oxygen concentration was between 60 and 100 per cent of the air saturation value 
(ASV) throughout the exposure period. 
• The water temperature did not differ by more than ± 2.0°C between test vessels at any one time 
during the exposure period.  
Collection of data and statistical analysis: 
19. All test results were collected and centrally analysed. Unless otherwise stated, a two-sided 
hypothesis testing was used. 
The statistical analysis of vitellogenin measurements were performed by John W Green (DuPont 
Applied Statistics) following a defined protocol (Figure 1) 
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Figure 1: Protocol for guidance in statistical analysis of VTG data 
20. The statistical analysis of phenotypic sex was also performed by John W Green following a 
defined protocol (Figure 2).  
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Statistics Flow-Diagram for Sex Ratio Response-NOEC
Is solvent used?
Yes No
Compare controls using t-test.  
Do controls differ?
Yes No
Drop water 
control†
Combine 
controls†
Are data consistent with 
monotone dose-response?
Yes No
Apply step-down 
Jonckheere-
Terpstra test + to 
determine NOEC
Are data normally distributed?*
Yes No
Use Dunnett test if homogeneous 
variances*, Tamhane-Dunnett (T3) test 
otherwise, to determine NOEC
Dunn or Mann-Whitney U-test w/ Bonferroni -
Holm adjustment to determine NOEC
† Or other agreed control selection
* After arcsin square-root transform
+ With fewer than 5 experimental units per treatment,  
exact J-T or M-W tests should be used if available.
 
Figure 2: Protocol for guidance in statistical analysis of sex ratio response 
 
 ENV/JM/MONO(2011)23 
 
 27
RESULTS 
 
Analytical chemistry 
  4-tert-octylphenol 
Table 2: Measured concentrations of 4-tert-octylphe nol; mean concentrations in µg/l ± the standard deviation (SD). Numbers in brackets are N samplings. Lines 
in Bold are means and SD of all treatment samples. Highlighted lines are outliers from the mean treatment concentration ± 20%. Lab 9 had nominal 
concentrations of 6.25, 12.5, 25, 50 and 100 µg/l 4-tert octylphenol. 
nominal 
conc. replicate 
LAB 1 zebrafish 
mean ± SD (n) 
LAB 2 zebrafish 
mean ± SD (n) 
LAB 4 medaka 
mean ± SD (n) 
LAB 4 zebrafish 
mean ± SD (n) 
LAB 5 medaka 
mean ± SD (n) 
LAB 6 stickleback 
mean ± SD (n) 
LAB 8 stickleback 
mean ± SD (n) 
LAB 9 medaka 
mean ± SD (n) 
control 
1 
2 
3 
4 
mean 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
 
<LOQ (3) 
<LOQ (3) 
<LOQ (3) 
<LOQ (3) 
 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
 
<LOQ (3) 
<LOQ (3) 
<LOQ (3) 
<LOQ (1) 
 
0.0 ± 0.0 (4)  
0.0 ± 0.0 (3)  
0.0 ± 0.0 (3) 
0.0 ± 0.0 (3) 
 
<1 µg/l (9) 
<1 µg/l (9) 
<1 µg/l (9) 
<1 µg/l (9) 
 
<1 µg/l (10) 
<1 µg/l (10) 
<1 µg/l (10) 
<1 µg/l (10) 
 
<LOQ (5) 
<LOQ (4) 
<LOQ (3) 
- 
- 
solvent 
1 
2 
3 
4 
mean 
- 
10.1± 15.6 (3) 
0.3 ± 0.6 (3) 
0.5 ± 0.9 (3) 
2.1 ± 2.4 (3) 
3.3 ± 4.9 (12) 
<LOQ (5) 
<LOQ (5) 
<LOQ (5) 
<LOQ (5) 
 
- - 
<1 µg/l (9) 
1.4 ± 2.6 (9) 
<1 µg/l (9) 
1.3 ± 2.3 (9) 
0.44 ± 0.8 (36)
<1 µg/l (10) 
<1 µg/l (10) 
<1 µg/l (10) 
<1 µg/l (10) 
 
- 
10 µg/l 
1 
2 
3 
4 
mean 
- - 
10.8 ± 3,9 (5) 
10.5 ± 2.4 (5) 
11.6 ± 2.0 (5) 
11.8 ± 2.3 (4) 
11.2 ± 2.6 (19) 
10.2 ± 2.8 (6) 
11.1 ± 3.4 (5) 
8.58 ± 1.6 (6) 
7.93 ± 1.7 (5) 
9.5 ± 2.5 (22)
15.0 ± 10.0 (4)  
13.3 ± 5.8 (3)  
10.0 ± 0.0 (3) 
10.0 ± 0.0 (3) 
12.1 ± 3.9 (13)
11.2 ± 3.3 (9)  
12.5 ± 2.3 (8)  
11.3 ± 1.2 (8) 
14.1 ± 1.9 (9) 
12.2 ± 2.6 (34)
- 
6.0 ± 0.8 (4)  
6.8 ± 0.6 (4)  
5.7 ± 0.4 (4) 
- 
6.2 ± 0.8 (12) 
32 µg/l 
1 
2 
3 
4 
mean 
 
 
 
 
13.8 ± 8.0 (12) 
6.9 ± 4.6 (3) 
3.0 ± 5.2 (3) 
5.6 ± 8.1 (3) 
7.4 ± 5.7 (3) 
5.7 ± 5.9 (12)
28.9 ± 6.3 (5) 
29.6 ± 7.6 (5) 
34.4 ± 10.2 (5) 
33.8 ± 10.5 (5)  
31.7 ± 8.5 (20)
27.7 ± 5.3 (6) 
27.5 ± 6.4 (5) 
27.1 ± 6.0 (6) 
21.6 ± 4.3 (5) 
26.0 ± 5.7 (22)
32.5 ± 12.6 (4)  
26.7 ± 5.8 (3)  
33.3 ± 15.3 (3) 
30.0 ± 0.0 (3) 
30.6 ± 8.4 (13)
21.7 ± 4.3 (9)  
22.7 ± 6.5 (9)  
pooled with rep 2
pooled with rep 2 
22.2 ± 5.4 (18)
42.8 ± 17.0 (9)  
37.5 ± 10.9 (8)  
44.5 ± 17.2 (8) 
42.8 ± 17.6 (9) 
41.9 ± 15.4 (34)
12.6 ± 1.4 (4)  
11.5 ± 0.9 (4)  
12.7 ± 2.5 (4) 
- 
12.3 ± 1.7 (12) 
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100 µg/l 
1 
2 
3 
4 
mean 
 
 
 
 
40.6 ± 8.0 (12) 
12.5± 19.1 (3) 
33.9 ± 22.2 (3) 
10.9 ± 18.8 (3) 
13.3 ± 18.2 (3) 
17.6 ± 19.4 (12)
98.7 ± 21.2 (5) 
102.2 ± 23.3 (5) 
116.0 ± 18.0 (5) 
102.0 ± 27.8 (5) 
104.7 ± 22.1 (20) 
87,6 ± 23,6 (6) 
93,2 ± 12,5 (4) 
95,6 ± 12,0 (6) 
89,6 ±10,1 (4) 
91.5 ± 15.4 (20)
105.0 ± 23.8 (4) 
86.7 ± 32.1 (3)  
103.3 ± 25.2 (3)
63.3 ± 41.6 (3) 
89.6 ± 30.7 (13)
66.9 ± 11.7 (9)  
pooled with rep 1 
pooled with rep 1 
pooled with rep 1 
66.9 ± 11.7 (9)
128.8 ± 17.8 (4)  
126.5 ± 13.9 (4)  
133.0 ± 115.3 (4)  
134.3 ± 16.3 (4) 
130.6 ± 14.6 (16)
25.2 ± 4.5 (4)  
21.1 ± 1.1 (4)  
24.4 ± 4.8 (4) 
- 
23.6 ± 4.0 (12) 
*200 µg/l 
320 µg/l 
 
1 
2 
3 
4 
mean 
 
 
 
 
73.1 ± 8.0 (12) 
37.3± 64.5 (3)* 
44.9 ± 41.3 (3)* 
39.6 ± 68.7 (3)* 
48.1 ± 39.5 (3)* 
42.5 ± 47.2 (12)*
- 
342,0 ± 41.2 (2) 
231,9 ± 0 (1) 
323,3 ± 0.78 (2) 
295,3 ± 0 (1) 
298.1 ± 45.6 (6) 
- - 
481.0 ± 195.2 (2) 
450.0 ± 159.8 (2) 
510.0 ± 241.8 (2) 
514.5 ± 228.4 (2) 
488.9 ± 160.2 (8)
52.3 ± 0.7 (4)  
48.7 ± 5.5 (4)  
50.1 ± 6.1 (4) 
- 
50.4 ± 4.6 (12) 
         
89.1 ± 7.1 (4)  
105.9 ± 13.2 (4)  
106.9 ± 9.9 (4) 
- 
100.6 ± 12.7 (12) 
 
Measured concentrations were generally close to nominal concentrations, except in LAB 1 and LAB 2 testing zebrafish, where measured 
concentrations were much lower than expected. 
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  Dihydrotestosterone 
Table 3: Measured concentrations of DHT; mean concentrations in ng/l ± the standard deviation (SD). Numbers in brackets are N samplings. Lines in Bold are 
means and SD of all treatment samples. Highlighted lines are outliers from the mean treatment concentration ± 20%. 
nominal 
conc. replicate 
LAB 1 zebrafish 
mean ± SD (n) 
LAB 2 zebrafish
mean ± SD (n) 
LAB 3 zebrafish 
mean ± SD (n) 
LAB 5 medaka 
mean ± SD (n) 
LAB 6 stickleback 
mean ± SD (n) 
LAB 8 stickleback 
mean ± SD (n) 
LAB 9 medaka 
mean ± SD (n) 
control 
1 
2 
3 
4 
mean 
0.1 ± 0.1 (10) 
1.4 ± 4.3 (10) 
9.5 ± 19.6 (10) 
35.1 ± 70.8 (10) 
11.5 ± 38.1 (40)* 
2.2 ± 1.9 (3) 
1.3 ± 1.6 (3) 
6.4 ± 7.2 (3) 
1.4 ± 1.6 (3) 
2.8 ± 4.0 (12)
0.4 ± 1.1 (8)  
0.1 ± 0.4 (8)  
0.3 ± 0.7 (7) 
0.7 ± 1.8 (7) 
0.4 ± 1.1 (30)
0.0 ± 0.0 (4)  
0.0 ± 0.0 (3)  
0.0 ± 0.0 (3) 
0.0 ± 0.0 (3) 
 
0.0 ± 0.0 (9)  
0.0 ± 0.0 (9)  
0.0 ± 0.0 (9) 
0.0 ± 0.0 (9) 
 
<LOQ (10) 
<LOQ (10) 
- 
- 
 
<LOQ (11) 
 
 
 
 
solvent 
1 
2 
3 
4 
mean 
- 
2.4 ± 2.0 (3) 
3.5 ± 1.8 (3) 
3.4 ± 2.5 (3) 
4.3 ± 5.4 (3) 
3.3 ± 2.8 (12)
0.4 ± 1.2 (8)  
1.0 ± 2.8 (8)  
1.9 ± 5.1 (7) 
2.1 ± 5.7 (7) 
1.3 ± 3.8 (30)
- 
0.0 ± 0.0 (9)  
0.0 ± 0.0 (9)  
0.0 ± 0.0 (9) 
0.0 ± 0.0 (9) 
 
<LOQ (10) 
<LOQ (10) 
- 
- 
 
- 
100 ng/l 
1 
2 
3 
4 
mean 
42.6 ± 56.0 (10) 
43.8 ± 47.4 (10) 
90.9 ± 198.5 (10) 
62.8 ± 84.8 (10) 
60.0 ± 111.3 (40) 
4.6 ± 1.0 (3) 
2.4 ± 0.7 (3) 
1.4 ± 1.2 (3) 
5.0 ± 5.1 (3) 
3.3 ± 2.8 (12)
20.8 ± 17.2 (8)  
16.8 ± 10.8 (8)  
24.5 ± 10.7 (7) 
21.0 ± 12.7 (7) 
20.6 ± 12.8 (30)
77.8 ± 62.9 (4)  
40.0 ± 47.8 (3)  
39.0 ± 28.7 (3) 
38.3 ± 24.1 (3) 
48.8 ± 40.9 (13) 
123.3 ± 19.7 (9)  
125.7 ± 30.3 (8)  
122.8 ± 24.8 (8) 
126.3 ± 26.3 (9) 
124.6 ± 24.5 (34)
186.4 ± 58.3 (9)  
209.2 ± 74.4 (9)  
204.7 ± 55.5 (9) 
208.9 ± 53.2 (9) 
202.3 ± 58.3 (36)
94.4 ± 12.4 (11) 
- 
- 
- 
94.4 ± 12.4 (11) 
320 ng/l 
1 
2 
3 
4 
mean 
142.9 ± 195.5 (10) 
204.5 ± 271.4 (10) 
123.4 ± 145.7 (10) 
112.3 ± 133.5 (10) 
145.8 ± 190.3 (40) 
3.9 ± 4.6 (3) 
2.1 ± 2,9 (3) 
3.9 ± 6.8 (3) 
3.5 ± 3.3 (3) 
3.3 ± 4.0 (12)
17.5 ± 14.5 (8) 
14.6 ± 12.2 (8)  
27.2 ± 15.5 (7) 
25.1 ± 19.5 (7) 
20.8 ± 15.6 (30)
188.0 ± 105.4 (4)  
150.4 ± 45.1 (3)  
140.8 ± 63.0 (3) 
139.2 ± 93.1 (3) 
154.6 ± 76.6 (13) 
263.7 ± 59.6 (9)  
273.6 ± 51.1 (9)  
264.8 ± 45.5 (9) 
280.2 ± 63.1 (9) 
270.6 ± 53.3 (36)
352.2 ± 92.5 (9)  
339.9 ± 82.9 (9)  
316.3 ± 82.9 (9) 
305.7 ± 58.7 (9) 
328.5 ± 79.8 (36)
314.9 ± 52.1 (11) 
- 
- 
- 
314.9 ± 52.1 (11) 
1000 ng/l 
1 
2 
3 
4 
mean 
228.2 ± 184.4 (10) 
303.6 ± 140.6 (10) 
228.5 ± 154.2 (10) 
330.2 ± 250.7 (10) 
272.6 ± 185.7 (40) 
13.2 ± 13,7 (3) 
16.9 ± 16.2 (3) 
1.4 ± 0.8 (3) 
4.2 ± 2.5 (3) 
8.7 ± 11.1 (12)
53.1 ± 29.0 (8)  
83.6 ± 52.7 (8)  
84.5 ± 87.8 (7) 
158.2 ± 200.6 (7) 
93.1 ± 110.9 (30)
628.8 ± 113.5 (4)  
765.0 ± 88.5(3)  
683.3 ± 161.7 (3) 
667.5 ± 66.3 (3) 
711.1 ± 107.5 (13) 
792.4 ± 155.9 (9)  
725.2 ± 125.9 (9)  
742.7 ± 138.5 (8)
690.3 ± 131.2 (8) 
738.9 ± 137.4 (34)
1125.3 ± 263.8 (9) 
1089.2 ± 251.8 (9)  
1116.9 ± 226.4 (9) 
894.2 ± 482.1 (9) 
1056.4 ± 324.6 (36)
1003.9 ± 126.6 (11) 
- 
- 
- 
1003.9 ± 126.6 (11) 
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In laboratories testing with zebrafish, measured concentrations were generally much lower than nominal concentrations, in particular in  
LAB 2, the highest concentration tested did not reach 10 ng/L instead of 1000 ng/L.  4-tert-pentylphenol 
Table 4: Measured concentrations of 4-tert-pentylphenol; mean concentrations in µg/l ± the standard deviation (SD). Numbers in brackets are N samplings. Lines 
in Bold are means and SD of all treatment samples.  
nominal 
conc. replicate 
LAB 9 medaka 
mean ± SD (n) 
LAB 10 medaka 
mean ± SD (n) 
control 
1 
2 
3 
4 
<LOQ (5) 
<LOQ (4) 
<LOQ (3) 
- 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
<LOQ (9) 
solvent 
1 
2 
3 
4 
- - 
32 µg/l 
1 
2 
3 
4 
mean 
32.8 ± 4.3 (5) 
31.5 ± 4.1 (4) 
29.7 ± 2.5 (3) 
- 
31.5 ± 3.7 (12) 
26.8 ± 2,9 (9) 
27.0 ± 2.4 (9) 
27.0 ± 2.0 (9) 
27.0 ± 2.3 (9) 
27.0 ± 2.8 (36)
100 µg/l 
1 
2 
3 
4 
mean 
111.0 ± 10.2 (5) 
101.1 ± 15.5 (4) 
97.1 ± 14.5 (3) 
- 
104.2 ± 13.4 (12) 
93.4 ± 6.1 (9) 
93.8 ± 6.1 (9) 
93.4 ± 7.0 (9) 
93.7 ± 5.7 (9) 
93.6 ± 5.9 (36)
320 µg/l 
1 
2 
3 
4 
mean 
324.3 ± 40.6 (5) 
324.0 ± 42.3 (4) 
298.5 ± 20.3 (3) 
- 
317.7 ± 36.0 (12) 
295.3 ± 19.7 (9) 
294.9 ± 18.2 (9) 
293.5 ± 18.3 (9) 
293.5 ± 17.1 (9) 
294.3 ± 17.6 (36)
 
All measured concentrations remained within the +/-20% range of nominal concentrations 
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  Flutamide 
Table 5: Measured concentrations of flutamide; mean concentrations in µg/l ± the standard deviation (SD). Numbers in brackets are N samplings. Lines in Bold 
are means and SD of all treatment samples. Highlighted lines are outliers from the mean treatment concentration ± 20%.  
nominal 
conc. replicate 
LAB 6 stickleback 
mean ± SD (n) 
control 
1 
2 
3 
4 
<LOQ (5) 
<LOQ (1) 
<LOQ (1) 
<LOQ (5) 
solvent 
1 
2 
3 
4 
<LOQ (5) 
<LOQ (1) 
<LOQ (5) 
<LOQ (1) 
32 µg/l 
1 
2 
3 
4 
mean 
42.2 ± 10.7 (5) 
17.2 ± (1) 
48.3 ± 4.9 (5) 
33.0 ± (1) 
41.9 ± 11.4 (12) 
100 µg/l 
1 
2 
3 
4 
mean 
125.6 ± (1) 
145.4 ± 18.0 (5) 
135.6 ± (1) 
137.1 ± 24.9 (5) 
139.4 ± 19.5 (12) 
320 µg/l 
1 
2 
3 
4 
mean 
373.2 ± (1) 
377.9 ± 42.5 (5) 
433.3 ± (1) 
388.4 ± 34.0 (5) 
386.5 ± 36.4 (12) 
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Measured test concentrations were generally within an acceptable range of variability around the nominal concentrations. 
  17β-estradiol (E2) 
Table 6: Measured concentrations of E2; mean concentrations in ng/l ± the standard deviation (SD). Numbers in brackets are N samplings. Lines in Bold are 
means and SD of all treatment samples. Highlighted lines are outliers from the mean treatment concentration ± 20%.   
nominal 
conc. replicate 
Lab 6 stickleback 
mean ± SD (n) 
control 
1 
2 
3 
4 
<LOQ (5) 
<LOQ (1) 
<LOQ (1) 
<LOQ (5) 
solvent 
1 
2 
3 
4 
<LOQ (5) 
<LOQ (1) 
1.8 ± 4.1 (5) 
<LOQ (1) 
32 ng/l 
1 
2 
3 
4 
mean 
29.2 ± (1) 
38.0 ± 5.2 (5) 
32.1 ± (1) 
38.0 ± 6.6 (5) 
36.8 ± 5.9 (12) 
100 ng/l 
1 
2 
3 
4 
mean 
111.2 ± 31.6 (5) 
103.5 ± 37.4 (5) 
63.0 ± (1) 
47.2 ± (1) 
98.6 ± 36.2 (12) 
320 ng/l 
1 
2 
3 
4 
mean 
380.1 ± (1) 
394.8 ± 67.5 (5) 
390.9 ± 63.7 (5) 
370.4 ± (1) 
389.9 ± 56.4 (12) 
Measured test concentrations were generally within an acceptable range of variability around the nominal concentrations. 
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Hatching rate and survival 
  4-tert-octylphenol 
Table 7: Hatching rate and survival from hatch to end of exposure (4-tert-octylphenol): Survival in percentage per replicate. Lines in Bold are means of all 
treatment samples. Highlighted lines are outliers from the validation criteria. Nominal concentrations for LAB 9 were 6.25, 12.5, 25, 50 and 100 µg/l 4-tert-
octylphenol 
nominal
conc. replicate 
LAB 1 zebrafish LAB 2 zebrafish LAB 4 medaka LAB 4 zebrafish LAB 5 medaka LAB 6 stickleback LAB 8 stickleback LAB 9 medaka 
Hatching 
rate (%)  
survival  
(%) (n) 
Hatching  
rate (%) 
survival 
(%) (n) 
Hatching 
rate (%)
survival 
(%) (n) 
Hatching 
rate (%)
survival 
(%) (n) 
Hatching 
rate (%) 
survival 
(%) (n) 
Hatching 
rate (%)
survival 
(%) (n) 
Hatching 
rate (%)
survival 
(%) (n) 
Hatching
rate (%)
survival  
(%) (n) 
control 
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
90.0 
95.0 
88.0 
83.0 
89.0 
100 
100 
100 
100 
100 
90.0 
88.0 
89.0 
89.0 
89.0 
70.0 
60.0 
90.0 
90.0 
77.5 
85.7 
100.0 
83.3 
83.3 
87.1 
100.0 
100.0 
97.5 
97.5 
98.8 
80.0 
70.0 
74.4 
66.7 
72.8 
76.0 
88.0 
84.0 
64.0 
78.0 
89.5 
90.9 
85.7 
100 
91.5 
77.0 
95.0  
80.0  
90.0  
95.0  
90.0 
60.0 
83.0 
90.0 
80.0 
78.3 
91.6 
95.8 
84.3 
100.0 
92.9 
80.0 
93.3 
80.0 
84.3 
80.0 
77.8 
80.0 
79.3 
solvent
1 
2 
3 
4 
mean 
 
- - 
100 
100 
100 
100 
100 
97.0 
98.0 
100.0 
95.0 
97.0
- - - - - - 77.2 
100.0  
90.0  
95.0  
80.0  
91.3 
53.3 
30.0 
83.3 
80.0 
61.7
87.5 
96.0 
88.0 
0.0 
67.9
  
10 µg/l
1 
2 
3 
4 
mean 
- - - - 
45.0 
45.0 
35.0 
35.0 
40.0 
88.9 
100.0 
100.0 
100.0 
96.9 
100.0 
100.0 
100.0 
100.0 
100.0
70.0 
72.5 
75.0 
65.0 
70.6 
100 
68.0 
88.0 
92.0 
87.0 
88.0 
88.2 
100 
95.7 
93.0 
76.4 
90.0  
69.1  
90.0  
90.0  
84.8 
  
93.3 
86.7 
93.3 
91.1 
80.0 
86.7 
93.3 
86.7 
32 µg/l
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
90.0 
100.0 
85.0 
90.0 
91.3 
100 
100 
100 
100 
100 
83.0 
79.0 
80.0 
95.0 
84.0
- 
- 
50.0 
80.0 
65.0 
- 
- 
100.0 
88.0 
92.3 
100.0 
100.0 
97.5 
95.0 
98.1 
62.5 
52.5 
71.8 
57.9 
61.2 
76.0 
76.0 
80.0 
80.0 
78.0 
100 
94.7 
100 
100 
98.7 
60.2 
75.9  
80.0  
Pooled  
Pooled 
78.0 
56.6 
26.6 
43.3 
80.0 
51.6 
100.0 
84.0 
94.7 
0.0 
69.7 
90.3 
100.0 
80.0 
91.1 
93.3 
93.3 
80.0 
88.9 
100 
µg/l 
1 
2 
3 
100.0 
100.0 
100.0 
85.0 
70.0 
88.0 
100 
100 
100 
85.0 
78.0 
86.0 
55.0 
70.0 
50.0 
90.9 
78.6 
90.0 
97.5 
100.0 
100.0 
43.6 
17.5 
27.5 
68.0 
84.0 
84.0 
88.2 
76.2 
100 
17.6 
65.2  
Pooled 
Pooled 
60.0 
22.5 
23.3 
2.7 
0.0 
0.0 
80.0 
93.3 
93.3 
73.3 
93.3 
93.3 
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4 
mean 
100.0 
100.0 
87.0 
82.5 
100 
100 
80.0 
82.0 
80.0 
63.8 
100.0
90.2 
95.0 
98.1 
36.8 
31.4 
96.0 
83.0 
100 
91.1 
Pooled 
65.2 
33.3 
34.8 
0.0 
0.7 
88.9 86.7 
*200 
µg/l 
320 
µg/l 
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
83.0* 
100.0* 
75.0* 
80.0* 
84.5* 
100 
100 
100 
100 
100 
86.0* 
79.0* 
79.0* 
85.0* 
82.0*
- - 
50 
32.5 
32.5 
22.5 
34.4 
0.0 
0.0 
0.0 
0.0 
0.0 
  - - 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0
73.3 
80.0 
100.0 
84.4 
73.3 
80.0 
80.0 
77.8 
                
100.0 
80.0 
86.7 
88.9 
93.3 
0 
73.3 
55.6 
 
  Dihydrotestosterone 
Table 8: hatching rate and survival from hatch to end of exposure (DHT): Survival in percentage per replicate. Lines in Bold are means of all treatment samples. 
Highlighted lines are outliers from the validation criteria. 
nominal 
conc. replicate 
LAB 1 zebrafish LAB 2 zebrafish LAB 3 zebrafish LAB 5 medaka LAB 6 stickleback LAB 8 stickleback LAB 9 medaka 
hatching  
rate (%)  
survival  
(%) (n) 
hatching 
rate (%) 
survival 
(%) (n) 
hatching 
rate (%) 
survival 
(%) (n) 
hatching 
rate (%) 
survival  
(%) (n) 
hatching 
rate (%) 
survival 
(%) (n) 
hatching 
rate (%) 
survival  
(%) (n) 
hatching  
rate (%) 
survival  
(%) (n) 
control 
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
45.0 
68.0 
43.0 
50.0 
51.5 
100.0 
100.0 
100.0 
100.0 
100.0 
85 
61.0 
63.0 
59.0 
67.0
93.3 
91.7 
95.0 
90.0 
92.5 
78.3 
80.0 
83.3 
76.7 
79.6 
80.0 
72.0 
80.0 
92.0 
81.0 
100 
88.9 
95.0 
100 
96.0 
77.0 
95.0  
80.0  
90.0  
95.0  
90.0 
60.0 
83.0 
90.0 
80.0 
78.3 
91.6 
95.8 
84.3 
100 
92.9 
100.0 
100.0 
95.0 
100.0 
98.8 
80.0 
85.0 
80.8 
100.0 
86.4 
solvent 
1 
2 
3 
4 
mean 
- - 
100.0 
100.0 
100.0 
100.0 
100.0 
72.0 
74.0 
76.0 
58.0 
70.0
95.0 
95.0 
96.7 
93.3 
95.0 
88.3 
45.0 
66.7 
70.0 
67.5 
- - 77.2 
100.0  
90.0  
95.0  
80.0  
91.3  
53.3 
30.0 
83.3 
80.0 
61.7 
87.5 
96.0 
88.0 
pooled 
90.5 
- - 
100 ng/l 
1 
2 
3 
100.0 
100.0 
100.0 
68.0 
73.0 
65.0 
100.0 
100.0 
100.0 
82.0 
79.0 
65.0 
95.0 
85.0 
96.7 
65.0 
65.0 
76,7 
96.0 
64.0 
64.0 
91.7 
100 
87.5 
84.7 
80.0  
90.0  
95.0  
83.3 
66.6 
43.2 
75.4 
90.5 
90.5 
95.0 
70.0 
85.0 
85.5 
49.0 
68.0 
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4 
mean 
100.0 
100.0 
55.0 
61.5 
100.0 
100.0 
51.0 
69.0 
98.3 
93.8 
80.0
71.7 
84.0 
77.0 
95.2 
93.6 
90.0  
84.8  
66.6 
64.9 
80.9 
84.3 
80.0 
82.5 
52.0 
63.6 
320 ng/l 
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
68.0 
73.0 
73.0 
55.0 
67.3 
100.0 
100.0 
100.0 
100.0 
100.0 
45.0 
65.0 
43.0 
49.0 
50.0
96.7 
88.3 
95.0 
96.7 
94.2 
96.7 
83.3 
60.0 
66.7 
76.7 
88.0 
80.0 
84.0 
64.0 
79.0 
90.9 
90.0 
100 
100 
95.2 
84.7 
76.0  
80.0  
Pooled 
Pooled 
78.0 
25.8 
56.6 
47.0 
40.0 
42.4 
100.0 
83.0 
93.7 
Pooled 
92.2 
100.0 
85.0 
95.0 
100.0 
95.0 
95.0 
68.0 
71.3 
80.0 
78.6 
1000 ng/l 
1 
2 
3 
4 
mean 
100.0 
100.0 
100.0 
100.0 
100.0 
85.0 
60.0 
68.0 
45.0 
64.5 
100.0 
100.0 
100.0 
100.0 
100.0 
55.0 
78.0 
61.0 
79.0 
68.0
93.3 
95.0 
96.7 
91.7 
94.2 
80.0 
81.7 
63.3 
50.0 
68.8 
80.0 
56.0 
64.0 
80.0 
70.0 
100 
100 
93.8 
90.0 
95.9 
85.5 
65.2  
Pooled 
Pooled 
Pooled 
65.2 
78.1 
56.6 
54.5 
50.0 
59.8 
100.0 
95.8 
90.4 
Pooled 
95.4 
90.0 
95.0 
85.0 
90.0 
90.0 
63.0 
80.8 
21.3 
76.5 
60.4 
 
  4-tert-pentylphenol 
Table 9: hatching rate and survival from hatch to end of exposure (4-tert-pentylphenol): Survival in percentage per replicate. Lines in Bold are means of all 
treatment samples. Highlighted lines are outliers from the validation criteria. 
nominal 
conc. replicate 
LAB 9 medaka LAB 10 medaka 
hatching  
rate (%) 
survival 
(%) (n) 
hatching 
rate (%) 
survival 
(%) (n) 
control 
1 
2 
3 
4 
mean 
86.7 
93.3 
93.3 
- 
91.1 
69.3 
80.9 
68.5 
- 
72.9 
90.0 
95.0 
95.0 
95.0 
93.8 
90.0 
95.0 
95.0 
85.0 
91.25 
solvent 
1 
2 
3 
4 
mean 
- - - - 
32 µg/l 1 2 
80.0 
93.3 
64.0 
87.1 
100.0 
100.0 
95.0 
95.0 
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3 
4 
mean 
80.0 
- 
84.4 
53.3 
- 
68.2 
100.0 
100.0 
100.0 
100.0 
100.0 
97.5 
100 µg/l 
1 
2 
3 
4 
mean 
93.3 
93.3 
93.3 
- 
93.3 
74.7 
80.9 
80.9 
- 
78.8 
100.0 
100.0 
100.0 
100.0 
100.0 
95.0 
90.0 
100.0 
90.0 
93.8 
320 µg/l 
1 
2 
3 
4 
mean 
100.0 
73.3 
86.7 
- 
86.7 
100.0 
53.8 
69.3 
- 
74.4 
100.0 
100.0 
100.0 
100.0 
100.0 
95.0 
85.0 
100.0 
95.0 
93.8 
 
  Flutamide 
Table 10: Hatching rate and survival from hatch to end of exposure (flutamide): Survival in percentage per replicate. Lines in Bold are means of all treatment 
samples. Highlighted lines are outliers from the validation criteria. 
nominal 
conc. replicate 
LAB 6 stickleback 
hatching  
rate (%) 
survival  
(%) (n) 
control 
1 
2 
3 
4 
mean 
50.0 
71.4 
75.0 
87.5 
71.0 
100.0 
Pooled 
Pooled 
92.3 
96.2 
solvent 
1 
2 
3 
4 
mean 
75.0 
85.7 
87.5 
75.0 
80.8 
100.0 
Pooled 
100.0 
Pooled 
100.0 
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32 µg/l 
1 
2 
3 
4 
mean 
83.3 
71.4 
90.0 
66.7 
77.9 
100.0 
Pooled 
89.5 
Pooled 
94.7 
100 µg/l 
1 
2 
3 
4 
mean 
81.8 
80.0 
85.7 
86.7 
83.6 
pooled 
95.8 
Pooled 
90.9 
93.4 
320 µg/l 
1 
2 
3 
4 
mean 
81.8 
90.0 
66.7 
83.3 
80.5 
Pooled 
94.4 
Pooled 
100.0 
97.2 
 
  17β-estradiol (E2) 
Table 11: hatching rate and survival from hatch to end of exposure (E2): Survival in percentage per replicate. Lines in Bold are means of all treatment samples. 
Highlighted lines are outliers from the validation criteria. 
nominal 
conc. replicate 
LAB 6 stickleback 
hatching  
rate (%) 
survival  
(%) (n) 
control 
1 
2 
3 
4 
mean 
50.0 
71.4 
75.0 
87.5 
71.0 
100.0 
Pooled 
Pooled 
92.3 
96.2 
solvent 
1 
2 
3 
4 
75.0 
85.7 
87.5 
75.0 
100.0 
Pooled 
100.0 
Pooled 
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mean 80.8 100.0 
32 ng/l 
1 
2 
3 
4 
mean 
71.4 
83.3 
50.0 
89.5 
73.6 
Pooled 
100.0 
Pooled 
100.0 
100.0 
100 ng/l 
1 
2 
3 
4 
mean 
88.9 
90.9 
80.0 
80.0 
85.0 
100.0 
100.0 
pooled 
Pooled 
100.0 
320 ng/l 
1 
2 
3 
4 
mean 
100.0 
90.9 
71.4 
83.3 
86.4 
Pooled 
94.1 
100.0 
Pooled 
97.1 
 
Abnormal appearance and behaviour 
No dose related abnormal appearance or behaviour was reported from the laboratories except for LAB 6 where male aggressive behaviour was 
registered (as number of nips) and a 4 fold reduction was observed at 739 ng/l DHT. A 1½ fold reduction was observed from 66.9 µg/l 4-tert-
octylphenol. 
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Core endpoints 
Table 12: Overview of NOEC/LOEC for vitellogenin measurements. *=Jonkheere Terpstra One-sided alternative hypothesis. 
Exposure chemical species Lab NOEC VTG (µg/l) LOEC VTG (µg/l) comments 
4-tert-octylphenol 
4-tert-octylphenol 
4-tert-octylphenol 
zebrafish 
zebrafish 
zebrafish 
1 
2 
4 
13.8 
17.6 
9.5 
40.6 
42.5 
26.0* 
increase undifferentiated 
increase females and males 
increase males 
4-tert-octylphenol 
4-tert-octylphenol 
4-tert-octylphenol 
medaka 
medaka 
medaka 
4 
5 
9 
31.7 
<12.1 
6.2 
105 
12.1 
12.3 
increase females 
increase undifferentiated 
increase males 
4-tert-octylphenol 
4-tert-octylphenol 
stickleback 
stickleback 
6 
8 
22.2 
>41.9 
66.9 
>41.9 
against solvent control only 
No effect 
DHT 
DHT 
DHT 
zebrafish 
zebrafish 
zebrafish 
1 
2 
3 
60.0 ng/l 
3.1 ng/l 
20.8 ng/l 
146 ng/l 
3.3 ng/l 
93.1* ng/l 
decline males 
No dose response 
increase males 
DHT 
DHT 
medaka 
medaka 
5 
9 
48.8 ng/l 
<94.0 ng/l 
155 ng/l 
94.4 ng/l 
decline females  
increase males 
DHT 
DHT 
stickleback 
stickleback 
6 
8 
739 ng/l 
<202 ng/l 
>739 ng/l 
202  ng/l 
no effect 
decline males, no dose response 
4-tert-pentylphenol 
4-tert-pentylphenol 
medaka 
medaka 
9 
10 
31.5 
<27.0 
104.2 
27.0 
increase males  
increase females 
E2 stickleback 6 36.8 ng/l 98.6 ng/l increase females and undiff. 
flutamide stickleback 6 41.9* 139 increase females 
ammonia zebrafish 1 1.94 mg/l 3.88 mg/l no dose response 
n-octanol medaka 9 1.0 mg/l 3.2 mg/l decline females 
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Table 13: Overview of NOEC/LOEC for sex ratio measurements 
Exposure chemical species Lab NOEC sex ratio (µg/l) LOEC sex ratio (µg/l) comments 
4-tert-octylphenol 
4-tert-octylphenol 
4-tert-octylphenol 
zebrafish 
zebrafish 
zebrafish 
1 
2 
4 
<13.8 
5.7 
9.5 
13.8 
17.6 
26.0 
more females 
less males 
more females 
4-tert-octylphenol 
4-tert-octylphenol 
4-tert-octylphenol 
medaka 
medaka 
medaka 
4 
5 
9 
<11.2 
<12.1 
23.5 
11.2 
30.6 
50.4 
more females 
more females 
more females 
4-tert-octylphenol 
4-tert-octylphenol 
stickleback 
stickleback 
6 
8 
66.0 
>41.9 
>66.0 
>41.9 
no males 
100% mortality above 41.9 µg/l 
DHT 
DHT 
DHT 
zebrafish 
zebrafish 
zebrafish 
1 
2 
3 
<60.0 ng/l 
>8.7 ng/l 
20.6 ng/l 
60.0 ng/l 
>8.7 ng/l 
20.8 ng/l 
more males 
low chemical concentration 
more males 
DHT 
DHT 
medaka 
medaka 
5 
9 
<48.8 ng/l 
<94.0 ng/l 
48.8 ng/l 
94.0 ng/l 
less females 
genetic females => males 
DHT 
DHT 
stickleback 
stickleback 
6 
8 
271 ng/l 
202 ng/l 
739 ng/l 
329 ng/l 
 One intersex fish in middle and 
two in high exposure conc. 
 
more intersex, less females 
4-tert-pentylphenol 
4-tert-pentylphenol 
medaka 
medaka 
9 
10 
104 
27.0 
318 
93.6 
genetic males => females  
more intersex 
E2 stickleback 6 98.6 ng/l 390 ng/l more intersex 
flutamide stickleback 6 >383 >383 no males 
ammonia zebrafish 1 >7.75 mg/l >7.75 mg/l 100% mortality at 15 mg/l 
n-octanol medaka 9 >3.2 mg/l >3.2 mg/l no effect 
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Zebrafish 
  4-tert-octylphenol 
Vitellogenin levels 
Table 14: Vitellogenin levels detected in male and female fish following exposure to 4-tert-octylphenol. Standard 
deviation is indicated in parenthesis. LAB 4 used 10, 32 and 100 µg/L as test concentrations. Shaded cell indicate the 
statistical significance. 
 Sex Control 32 µg/L 100 µg/L  200 µg/L 
LAB 1 Males 4036 (34751) 83 (52) - - 
 Females 261 915 (226 671) 193 729 (271 226) 162 690 (460 756) 6 606 446 (3 572 973) 
 Undiff. 22 402 (66 974) 1 848 (4 535) 158 705 (485 012) 5 716 012 (3561 727) 
LAB 2 Males 1129 (2521) 
[solvent control: 
54 (58] 
2178 (8510) 678 (3098) 26 797 (39 265) 
 Females 352 251 (629 865) 
[solvent control: 
25 101 (56634)] 
49 735 (222 099) 13422 (47 939) 354 966 (887 221) 
 Undiff 23 038 (54 416) 
[solvent control: 
1395 (4873)] 
2544 (10 045) 41 (62) 66 169 (215 054) 
LAB 4 Males 11 (6) 11 (5) 22 (19) - 
 Undiff. 12 (7) 10 (5) 694 (1655) 241 925 (270 745) 
 Intersex. 10 (6) 13 (11) 1 444 (2 037) 157 801 (159 027) 
 Females 18 808 (52 405) 3 751 (7 427) 12 756 (28 091) 184 347 (230 426) 
 
Sex ratio  
Table 15: Proportions of each sex determined following exposure to 4-tert-octylphenol. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance 
 Proportions (SD) Control 10 µg/L 32 µg/L 100 µg/L  200 µg/L 
LAB 1 Males 0.567 (0.06) ----------- 0.184 (0.23) 0 0 
 Females 0.355 (0.07) ----------- 0.762 (0.22) 0.563 (0.12) 0.628 (0.03) 
 Intersex 0.014 (0.03) ------------ 0 0 0 
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 Undifferentiated 0.064 (0.03) ------------ 0.054 (0.06) 0.438 (0.12) 0.372 (0.03) 
LAB 2 Males 0.369 (0.99) ------------ 0.285 (0.79) 0.193 (0.46) 0.07 (0.28) 
 Females 0.479 (0.46) ------------ 0.523 (0.80) 0.496 (0.19) 0.525 (0.56) 
 Intersex None ------------ None None None 
 Undifferentiated 0.150 (0.79)) ------------ 0.192 (0.17) 0.309 (0.37) 0.400 (0.31) 
LAB 4 Males 0.409 (0.08) 0.274 (0.13) 0.104 (0.09) 0 ---------------- 
 Females 0.461 (0.05) 0.619 (0.14) 0.729 (0.06) 0.633 (0.18) ---------------- 
 Not Intersex 0.954 (0.03) 0.938 (0.04) 0.978 (0.02) 0.870 (0.12) ---------------- 
 Not 
Undifferentiated 
0.964 (0.05) 0.973 (0.03) 0.891 (0.02) 0.765 (0.18) ---------------- 
 
  Dihydrotestosterone (DHT) 
Vitellogenin levels 
Table 16: Vitellogenin levels detected in male and female fish following exposure to dihydrotestosterone. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 1 Males 288 (668) 51 814  
(314 747) 
37 (13) 26 (11) 
 Females 1 333 455  
(1 671 066) 
633 262  
(1 478 884) 
- - 
LAB 2 Males 363 (1 203) 40 (23) 3545 (17 744) 5 641 (18 302) 
 Females 587 960  
(1 128 779) 
[solvent control: 
34 497 (66 562)] 
1 692 (5 082) 162 958  
(467 117) 
85 829 
(284 038) 
LAB 3 Males 35 (36) 53 (43) 78 (111) 61 (39) 
 Females 9 076 (32 187) 5 044 (16 518) 15 559  
(41 956) 
265 (193) 
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Sex ratio  
Table 17: Proportions of each sex determined following exposure to dihydrotestosterone. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions (SD) Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 1 Males 0.561 (0.26) 0.837 (0.80) 1 (0) 0.99 (0.08) 
 Females 0.390 (0.22) 0.163 (0.80) 0 0 
 Intersex 0 0 0 0.010 (0) 
 Undifferentiated 0.049 (0) 0 0 0 
LAB 2 Males 0.559 (0.54) 0.50 (0.77) 0.586 (0.41) 0.57 (0.38) 
 Females 0.394 (0.58) 0.353 (0.70) 0.363 (0.60) 0.331 (0.27) 
 Intersex None None None None 
 Undifferentiated 0.044 (0.05) 0.145 (0.11) 0.061 (0.06) 0.098 (0.02) 
LAB 3 Not Males 0.400 (0.03) 0.298 (0.16) 0.161 (0.20) 0.087 (0.14) 
 Females 0.400 (0.03) 0.287 (0.15) 0.148 (0.17) 0.087 (0.14) 
 Intersex ------------ ------------ ------------ ------------ 
 Undifferentiated ------------ ------------ ------------ ------------ 
 
Medaka 
  4-tert-octylphenol 
Vitellogenin levels 
Table 18: Vitellogenin levels detected in male and female fish following exposure to 4-tert-octylphenol. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 10 µg/L 32 µg/L  100 µg/L 
LAB 4 Males <limit of 
quantification 
<limit of 
quantification 
<limit of 
quantification 
<limit of 
quantification 
 Females 9 (6) 32 (73) 25 (38) 153 (104) 
LAB 5 Males 128 (18) 7 165 (36 614) 134 (27) 2629 (6 972) 
 Females 6128 (15460) 10 122 (30 584) 27 445  59 599  
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(44 327) (93 915) 
LAB 9 Males 0.7 (0.1) 6 (7) 31 (21) - 
 Females 1711 (412) 1170 (415) 1180 (542) 2132 (298) 
 
Sex ratio  
Table 19: Proportions of each sex determined following exposure to 4-tert-octylphenol. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions (SD) Control 10 µg/L 32 µg/L  100 µg/L 
LAB 4 Males 0.666 (0.57) 0.451 (0.58) 0.296 (0.23) 0.043 (0.15) 
 Females 0.203 (0.58) 0.483 (0.60) 0.444 (0.59) 0.478 (0.55) 
 Intersex 0 0.032 (0.19) 0.185 (0.48) 0.413 (0.29) 
 Undifferentiated 0.129 (0.31) 0.032 (0.19) 0.074 (0.26) 0.065 (0.24) 
LAB 5 Males 0.500 0.406 0.452 0.317 
 Not Females 0.569 0.440 0.452 0.393 
 Intersex ---------- --------- ----------- ---------- 
 Undifferentiated ---------- ---------- ----------- ---------- 
LAB 9 Males 0.519 (0.081) 0.425 (0.115) 0.610 (0.091) 0 (0) 
 Females 0.481 (0.081 0.575 (0.115) 0.390 (0.091) 1 (0) 
 
  Dihydrotestosterone 
Vitellogenin levels 
Table 20: Vitellogenin levels detected in male and female fish following exposure to dihydrotestosterone. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 5 Males 161 (223) 128 (15) 125 (0.2) 132 (24) 
 Females 14 101 (21 365) 13 230 (23 977) 3 919 (7 589) - 
LAB 9 Males 0.5 (0.7) 15 (58) 18 (39) 19 (29) 
 Females 329 (320) 402 (195) 179 (125) - 
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Sex ratio  
Table 21: Proportions of each sex determined following exposure to dihydrotestosterone. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 5 Not Males 0.499 0.394 0.060 0.048 
 Females 0.430 0.299 0.060 0 
 Intersex ----------- -------------- --------------- ------------- 
 Undifferentiated ------------- ---------------- ------------ ------------- 
LAB 9 Males 0.486 0.458 0.652 1 
 Females 0.514 0.542 0.348 0 
 Intersex ----------- ------------ ------------ ------------- 
 Undifferentiated ----------- ------------ ------------ ------------- 
 
  4-tert-pentylphenol 
Vitellogenin levels 
Table 22: Vitellogenin levels detected in male and female fish following exposure to 4-tert-pentylphenol. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 32 µg/L 100 µg/L  320 µg/L 
LAB 9 (70d) Males 1.2 (0.3) 1.3 (0.7) 1.7 (0.2) 3 (2) 
 Females 882 (513) 613 (172) 767 (417) - 
LAB 10 (60d) Males 0.68 (0.5) 0.90 (0.88) 2.45 (2.95) 85 (156) 
 Females 1019 (736) 1719 (649) 3215 (1480) 5099 (4427) 
 
Sex ratio  
Table 23: Proportions of each sex determined following exposure to 4-tert-pentylphenol. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance (*=one-sided hypothesis testing). 
 Proportion (SD) Control 10 µg/L 32 µg/L  100 µg/L 
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LAB 9 (70d) Males 0.551 0.411 0.403 0.304* 
 Females 0.448 (0.08) 0.588 (0.08) 0.596 (0.06) 0.521 (0.07) 
 Intersex ----------- ----------- ----------- ----------- 
 Undifferentiated ----------- ----------- ----------- ----------- 
LAB 10 (60d) Males 0.45 0.40 0.35 0.20 
 Females 0.55 0.60 0.50 0.70 
 Intersex ------------ ------------- 0.15 0.10 
 Undifferentiated ------------ ------------- ----------- ------------- 
 
 
Stickleback 
  4-tert-octylphenol 
Vitellogenin levels 
Table 24: Vitellogenin levels detected in males and female fish following exposure to 4-tert-octylphenol. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 32 µg/L 100 µg/L  200 µg/L 
LAB 6 Males 35 (34) 
Solvent control: 79 (54) 
42 (25) 42 (20) 83 431  
(74 047) 
 Females 43 (38) 
Solvent control: 72 (37) 
36 (28) 40 (25) 168 842  
(192 588) 
LAB 8 Males 1632 (566) 2222 (1972) - - 
 Females 1845 (813) 5724 (7766) - - 
 
Sex ratio  
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Table 25: Proportions of each sex determined following exposure to 4-tert-octylphenol. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions (SD) Control 32 µg/L 100 µg/L  200 µg/L 
LAB 6 Males 0.462 (0.30) 0.555 (0.44) 0.372 (0.44) 0.533 
 Females 0.537 (0.30) 0.444 (0.44) 0.558 (0.56) 0.466 
 Intersex None None 0.069 (0.12) None 
 Undifferentiated None None None None 
LAB 8 Males 0.389 (0.17) 0.547 (0.06) -------------- -------------- 
 Females 0.611 (0.17) 0.453 (0.06) -------------- -------------- 
 Intersex None None None None 
 Undifferentiated None None --------------- --------------- 
 
  Dihydrotestosterone 
Vitellogenin levels 
Table 26: Vitellogenin levels detected in male and female fish following exposure to dihydrotestosterone. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 6 Males 35 (34) 
Solvent control:79 (54) 
57 (47) 53 (35) 58 (62) 
 Females 43 (38) 
Solvent control:72 (47) 
54 (42) 49 (40) 42 (36) 
LAB 8 Males 1687 (2129) 621 (441) 815 (586) 1990 (2855) 
 Females 1965 (2014) 859 (496) 209 (272) 1283 (644) 
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Sex ratio 
Table 27: Proportions of each sex determined following exposure to dihydrotestosterone. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions (SD) Control 100 ng/L 320 ng/L  1000 ng/L 
LAB 6 Males 0.463 (0.07) 0.428 (0.14) 0.430 (0.11) 0.440 (0.18) 
 Females 0.536 (0.07) 0.571 (0.14) 0.555 (0.09) 0.529 (0.12) 
 Intersex ------------- ------------- 0.016 (0.03) 0.031 (0.06) 
 Undifferentiated ------------- ------------- ------------- ------------- 
LAB 8 Males 0.509 (0.80) 0.513 (0.95) 0.612 (0.04) 0.446 (0.17) 
 Females 0.490 (0.80) 0.486 (0.95) 0.308 (0.07) 0.412* (0.16) 
 Intersex 0 0 0.081* (0.03) 0.143* (0.05) 
 Undifferentiated 0 0 0 0 
 
  Flutamide 
Vitellogenin levels 
Table 28: Vitellogenin levels detected in male and female fish following exposure to flutamide for 42 dph. Standard 
deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 45 µg/L 141 µg/L  383 µg/L 
LAB 6 Undiff. 95 (212) 54 (13) 57 (8) 52 (7) 
 Females 49 (12) 51 (11) 56 (19) 71 (70) 
 
Sex ratio  
Table 29: Proportions of each sex determined following exposure to flutamide for 42 dph. Standard deviation is 
indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Proportions (SD) Control 45 µg/L 141 µg/L  383 µg/L 
LAB 6 Males None None None None 
 Females 0.608 (0.382) 0.558 (0.02) 0.578 (1.43) 0.583 (0.22) 
 Intersex -------------- -------------- -------------- ------------- 
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 Undifferentiated 0.391 (0.38) 0.441 (0.02) 0.421 (1.43) 0.416 (0.22) 
 
  17ß-estradiol 
Vitellogenin levels 
Table 30: Vitellogenin levels detected in male and female fish following exposure to 17ß-estradiol for 42 dph. 
Standard deviation is indicated in parenthesis. Shaded cell indicate the statistical significance. 
 Sex Control 100 µg/L 320 µg/L  1000 µg/L 
LAB 6 Undiff. 95 (212) 55 (23) 1 059 086  
(542 386) 
1 314 685 
(4 455 324) 
 Females 49 (12) 56 (15) 1 143 310  
(743 571) 
10 167 541 
(3 360 089) 
 
Sex ratio  
Table 31:  Proportions of each sex determined following exposure to 17ß-estradiol for 42 dph. 
 Proportions (SD) Control 32 µg/L 100 µg/L  320 µg/L 
LAB 6 Males None None None None 
 Females 0.608 (0.38) 0.464 (0.041) 0.366 (1.14) 0.562 (0) 
 Intersex 0 0 0.033 (0.19) 0.156* (0.53) 
 Undifferentiated 0.391 (0.38) 0.535 (0.04) 0.600 (0.95) 0.281 (0.53) 
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DISCUSSION 
Purpose of the assay 
The purpose of the Fish Sexual Development Test (FSDT) is to assess early life-stage effects and potential 
adverse consequences of putative endocrine disrupting chemicals (e.g., estrogens, androgens and 
steroidogenesis inhibitors). The combination of the two core endocrine endpoints, vitellogenin 
concentration and the population-relevant sex ratio enable the test to be used for hazard and risk 
assessment when the mode of action of the test substance is already known or identified by the FSDT. 
The biological model 
The biological model utilized in the Fish Sexual Development Test is the hormone regulated sexual 
differentiation and development in fish, where substances mimicking, inducing or inhibiting the 
endogenous hormones can skew the sex ratio of a sexual developing fish population toward more females, 
more males, more intersex fish or more undifferentiated fish. Besides, the hormone dependant induction or 
inhibition of the yolk protein vitellogenin (VTG) (see also OECD TG 229 and TG 230) is utilized in 
combination with the sex ratio to establish an identification of the mode of action (MOA) of the substance 
as demonstrated in Table 32. 
MOA VTG 
♂   
VTG 
♀ 
Sex ratio references 
Weak estrogen agonist ↑ ↑ ↑♀, ↑Undiff  [Panter et al. 2006;Schafers et al. 
2007] 
Strong estrogen agonist ↑ ↑ ↑♀ , ↑Undiff, No ♂ [Holbech et al. 2006;Schafers et al. 
2007] 
Estrogen antagonist ? ↓ ↓♀, ↑Undiff.  [Andersen et al. 2004] 
Weak androgen agonist ? ? ? ♂  
Strong androgen agonist ↓ ↓ ↑ ♂, No ♀ [Holbech et al. 2006] 
Androgen antagonist  - ↑ ↑intersex [Kiparissis et al. 2003;Panter et al. 
2004] 
aromatase inhibitor  ↓ ↓ ↓♀ [Kinnberg et al. 2007] 
Table 32: Effect response table of VTG and sex ratio to different modes of action of chemicals.  ↑=rise in VTG 
concentration or phenotypic sex.  ↓= decline in VTG concentration or phenotypic sex. 
Control animal performance: Hatching and Survival, abnormal appearance and behaviour 
The Hatching rate in the experiments with 4-tert-octylphenol did fulfil the validity criteria of 80% with 
exception of four experiments where the hatching rate was 77.5%, 78% and 77.3 and 78% respectively. 
These small abbreviations from the validity criteria are not expected to influence the results. Non of the 
laboratories reported any dose related delay in hatching. The survival of larvae and juvenile fish did fulfil 
the validity criteria of 70% in all experiments with 4-tert-octylphenol. In summary the hatching and 
survival in the eight experiments with 4-tert-octylphenol were satisfactory. 
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The hatching rate in all experiments with DHT did fulfil the validity criteria of 80% with exception of two 
experiments where the hatching rate was 77.0 and 78.3% which did not influence the test results. The 
survival of larvae and juvenile fish did fulfil the validity criteria of 70% in all experiments with 
dihydrotestosterone with the exception of two experiments where the survival rate was 51.5% and 67.0% 
respectively. The results of the first experiment however, were comparable to the results of the other 
experiments and therefore the aberration from the validity criteria are not expected to influence the results. 
The second experiment failed in keeping the DHT nominal concentration in acceptable levels but the 
survival was close to the 70% validity criteria and did not affect the results. In summary the hatching and 
survival in the eight experiments with dihydrotestosterone were satisfactory. 
The Hatching rate in the two experiments with 4-tert-pentylphenol did fulfil the validity criteria of 80%. 
The survival of larvae and juvenile fish did fulfil the validity criteria of 70% in both experiments with 
dihydrotestosterone. In summary the hatching and survival in the two experiments with 4-tert-pentylphenol 
were satisfactory. 
The Hatching rate in the experiments with 17ß-estradiol and flutamide (same control groups) did not 
fulfil the validity criteria of 80% as it was 71%. The survival of larvae and juvenile fish did fulfil the 
validity criteria of 70% in both experiments. In summary the hatching and survival in the two experiments 
with 17ß-estradiol and flutamide were satisfactory. 
LAB 6 reported a reduction in male aggressive behaviour (registered as number of nips) during the 
exposures. A 4 fold reduction was observed at 739 ng/l DHT and a 1½ fold reduction was observed at 66.9 
µg/l 4-tert-octylphenol. The reduced aggressive behaviour during DHT exposure was not expected but 
might be related to a negative feed back mechanism (on e.g. 11-keto testosterone, that is known to induce 
this male aggressive behaviour [Bell 2001]) but this has not been confirmed experimentally. The effect of 
4-tert-octylphenol is expected because it has previously been observed in stickleback that an estrogen 
reduces male aggressive behaviour [Bell 2001]. It should though be noted that the reference study was 
done with adult males in contrast to 0-60 DPH males in the present study. No other laboratories reported 
any dose related abnormal appearance or behaviour. Single cases of lordosis (curvature of the vertebral 
column) were observed in some of the laboratories but at a very low rate, unrelated to the test substance 
and probably something common in different laboratory stocks.  
Actual chemical water concentrations 
The actual chemical water concentration was measured in all experiments. Especially for the experiments 
with zebrafish, these concentrations were much below the nominal concentrations which is not satisfactory. 
Especially the exposure concentrations in the Lab 2 experiments are outliers and the results of these two 
experiments can not be compared to the rest. The endpoint responses are though strongly connected to the 
actual chemical concentrations which can be seen on the NOEC/LOEC values of Table 12 and Table 13 
and therefore the experiments are recognised as valid. The results confirm the necessity of regular 
chemical analysis of the exposure water and raise the question about exposure system design. A guidance 
document on aquatic flow through test systems might be a good idea. 
Vitellogenin response 
Vitellogenin is also a biomarker in TG 229 and TG 230 and the issue of inter laboratory comparison and 
variation in the response has been addressed in the validation process of these TGs. The vitellogenin 
response in the FSDT, where hazard and risk assessment could be relevant, should be seen in connection 
with the sex ratio because the skewing of the sex ratio where genetic sex is changed phenotypically can 
affect the vitellogenin concentration as seen in Figure 15 D where the vitellogenin concentration is 
significant different between genetic males and phenotypically sex reversed females. In contrast to TG 229 
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and TG 230, the FSDT should be able to identify the mode of action of the test substance and in this 
context, the sex specific changes in the VTG concentrations is a key biomarker as it can be seen from the 
effect contingency table in the FSDT draft proposal. One should also take into account that the FSDT is 
designed to be terminated as soon as the fish are sexually differentiated. This means that the size and 
developmental stages can vary significantly between experiments and therefore the background 
vitellogenin concentration can also vary between experiments as it is affected by these parameters. It is 
therefore expected to see higher control variability in the FSDT vitellogenin than in adult assays as TG 229 
and TG 230 vitellogenin but this should not affect the FSDT results because induction or reduction in 
vitellogenin is normally massive in response to chemicals ([Kinnberg et al. 2007;Zerulla et al. 2002], and 
because the vitellogenin response should always be connected to the sex ratio response as discussed above.  
Sex ratio response 
The skewing of the sex ratio can be a population relevant endpoint if the skewing causes a reproductive 
performance decline in the affected fish population. The size of the skewing of the sex ratio that will cause 
a population relevant effect is dependent on the reproductive strategy of the species. The differences in the 
sensitivity of species have been demonstrated in a whole lake exposure scenario where EE2 was introduced 
for three years and different fish populations were followed [Kidd et al. 2007;Palace et al. 2009]. 
The sex ratio skewing in the present FSDT validation and in published literature, where FSDT-like 
exposure scenarios were used, demonstrate a very strong response toward both estrogens, androgens and 
aromatase inhibitors and often a 100% effect on either phenotypic females or males are seen [Holbech et 
al. 2006;Kinnberg et al. 2007;Lange et al. 2001;Morthorst et al. 2010;Panter et al. 2006]. Due to this strong 
response scenario a rather marked change in the sex ratio could be defined as the threshold for a population 
relevant effect on the sex ratio. For example a 50% change in female or male phenotype proportions could 
be set as the threshold. The size of the population relevant effect threshold should though be discussed and 
decided in the FDG and/or VMG-Eco. A skewing toward more undifferentiated fish is not necessarily 
population relevant but can be so if for example the delay in sexual development of one of the sexes causes 
an asynchronous mating behaviour that affect breeding. The effects of intersex on fish populations are 
probably very much dependant on the severity of the intersex as well as the percentage of fish with intersex 
and also whether it is genetic females or males that turn into intersex fish.  
It should be noted that in the present validation report and in the FSDT draft proposal, sex ratio is defined 
as proportions of sex, where sex can be females, males, intersex or undifferentiated. The statistics are made 
on each of the four sex-definitions based on these proportions. As an example females are tested against all 
other fish (non-females) and males are tested against all other fish (non-males). Therefore, a significant 
change related to “more females” does not automatically mean “fewer males” because the proportions of 
intersex and undifferentiated can also change. The NOEC/LOEC data in Table 13 are based on the most 
sensitive change in each experiment and this is the cause of the different statements as “more females”, 
“more intersex” or “less males”. 
Genetic sex determination  
The determination of the genetic sex of the individual fish is currently possible for Japanese medaka and 
three spined stickleback. It improves the power of the test because it can identify each single fish that 
changes phenotypic sex in contrast to gonadal sexing alone where there is a need of a significant skewing 
of a proportion of sex before phenotypic sex reversal can be addressed. Beside, genetic sex determination 
clarifies the difference in vitellogenin concentrations between genetic males and sex reversed females and 
potentially also between genetic females and sex reversed males. 
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Guidance on the determination of genetic sex in Japanese medaka has been included in the FSDT draft 
proposal as an appendix. 
Performance of endpoints 
Hatching and survival 
A significant decline in the hatching rate was seen in the experiment with 4-tert-octylphenol and zebrafish 
in LAB 4 at 298 µg/l. The survival was affected at both 91.5 and 298 µg/l. In LAB 8, 4-tert-octylphenol 
caused a significant reduction in both the hatching rate and the survival in stickleback at 131 µg/l. at 489 
µg/l no surviving larvae were observed. A decline in hatching was also seen in stickleback at 66.9 µg/l in 
LAB 6. It seems as sticklebacks and zebrafish are slightly more sensitive to 4-tert-octylphenol than 
Japanese medaka where actual concentrations between 89.6 and 105 µg/l did affect neither hatching nor 
survival in the three experiments (LAB 4, 5 and 9). The results on medaka are in line with Seki et al., 
[2003] who found no effect on hatch or survival of 94 µg/l 4-tert-octylphenol. 
Vitellogenin: 
Vitellogenin was measured in head/tail homogenate or plasma in zebrafish, in head/tail homogenate in 
stickleback and in liver homogenate or plasma in medaka. Table 12 presents vitellogenin NOEC/LOEC 
values from all laboratories. 
In all experiments with 4-tert-octylphenol, NOECs were equal to or below 41.9 µg/l with the lowest values 
of 6.2 µg/l for medaka (comparable to a NOEC of 6.9 µg/l in Seki et al. ([2003]), 9.5 µg/l for zebrafish and 
22.2 µg/l for stickleback. The mean NOEC from all these experiments was 19.4 µg/l with a standard 
deviation of 12.1 µg/l. These data are very consistent seen in the context of 8 different experiments with 
three different species. It is important to underline that the VTG data should not be validated alone but in 
combination with the sex ratio data. 
The NOECs from the experiments with DHT varied from 739 ng/l in stickleback to  20.8 ng/l in zebrafish. 
Lab 2 was not included in the calculations due to low test concentrations. The mean NOEC from the 6 
experiments was 194 ng/l with a standard deviation of 274 ng/l. The high variability was partly caused by 
large inter species differences and partly by the fact that the female phenotype disappeared in several of the 
experiments at medium or high exposure concentrations which make a significant decline in VTG difficult 
to obtain. 
Two experiments were performed with medaka and 4-tert-pentylphenol. The NOECs were 31.5 µg/l and 
27.0 µg/l respectively, which give a mean of 29.3 µg/l and a standard deviation of 3.2 µg/l. These data are 
comparable to the validation Phase 1 results of 32 µg/l in zebrafish and 36 µg/l in fathead minnow.  
E2 and flutamide was tested in stickleback only but the E2 NOEC of 36.8 ng/l is comparable to the results 
in zebrafish from a published studies [Holbech et al. 2006]. 
One negative study with ammonia was performed on zebrafish. No effect was observed on female VTG 
but a non dose related effect was seen on male VTG with a significant induction in the medium exposure 
concentration (3.88 mg/l). No effect in the highest exposure concentration was seen and these variable 
results are probably seen because to few a number of fish were analysed for VTG (<20 for each sex). A 
negative study with n-octanol was performed on medaka. No effect on male VTG was observed whereas a 
slight but significant reduction in female VTG was seen at the highest exposure concentration. A reduction 
in VTG can be caused by a toxic effect on the liver of the fish at his concentration (3.20 mg/l). 
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Sex ratio 
The sexing of fish was performed by histological evaluation of the gonads. Fish were identified asfemales, 
males, intersex or undifferentiated. The statistics were calculated on basis of the proportions of sex and 
replicates were taken into account to include between replicate variations. 
The six 4-tert-octylphenol experiments with zebrafish and medaka all produced NOECs from 23.5 µg/l or 
below and LOEC´s from 50.4 µg/l or below (Table 13). The mean NOEC was 12.6 µg/l with a standard 
deviation of 6.0 µg/l and the mean LOEC was 24.9 µg/l with a standard deviation of 14.5 µg/l. These 
results are uniform and it can be concluded that zebrafish and medaka are equally sensitive to this weak 
estrogen and different laboratory populations of the two species perform equally. The medaka results are 
also comparable to published results with a NOEC/LOEC of 23.7/48.1 µg/l 4-tert-octylphenol [Seki et al. 
2003]. 
The results from the two experiments with stickleback suggest that phenotypic sex reversal in this species 
is less sensitive to 4-tert-octylphenol than in zebrafish and Japanese medaka because no LOEC was found. 
A higher systemic toxicity of 4-tert octylphenol to stickleback than to zebrafish and medaka could also be a 
part of the explanation of lack of effect. 
Five experiments were including zebrafish and medaka to DHT exposure. The Lab 2 experiment failed due 
to a maximum measured test concentration of 8.7 ng/l (nominal 1000 ng/l) and the results from this test can 
only be used as a “negative” study showing background sex ratio in zebrafish. The remaining four studies 
had NOECs below 94.4 ng/l for medaka and 60.0 ng/l for zebrafish and LOEC´s from 94.4 ng/l and below 
for medaka and 60.0 ng/l and below for zebrafish. The mean NOEC was 56.4 ng/l with a standard 
deviation of 30.2 ng/l and the mean LOEC was 56.5 ng/l with a standard deviation of 30.1 ng/l. These 
results are also very uniform and it can be concluded that medaka and zebrafish are equally sensitive to the 
androgen DHT. 
Two experiments were including stickleback to DHT exposure. with Lab 6 finding a NOEC of 739 ng/l 
and no LOEC and Lab 8 finding a NOEC of 202 ng/l and a LOEC of 329 ng/l expressed as intersex fish. 
The results indicate that in stickleback it is more difficult to reverse the phenotypic sex compared to 
medaka and zebrafish. 
Two studies were performed on medaka with 4-tert-pentylphenol exposure. NOECs were 27.0 µg/l and 
104.2 µg/l which can be compared to the NOEC´s of 32 µg/l, 34 µg/l and 36 µg/l in the three valid studies 
on zebrafish and fathead minnow in the phase 1 validation. 
A NOEC of 98.6 ng/l and a LOEC of 390 ng/l (more intersex fish and 13% genetic males changed to 
phenotypic females) was found in the study on E2 from Lab 6, whereas no LOEC was found in the study 
on flutamide in stickleback from Lab 6. The NOEC of 98.6 ng/l in the E2 study is higher than published 
studies on zebrafish and Japanese medaka where NOEC was below 50 ng E2/l, e.g. 24 ng/l [Holbech et al. 
2006] and below 33.5 ng/l [Hirai et al. 2006]. Again, it is evident that at least in the populations of 
stickleback used for the validation work it is difficult to chemically skew in regard to sex ratio. It should be 
noted that for both experiments (E2 and flutamide) the exposure was terminated at 42 dph, which explain 
why all undifferentiated fish were genetic males. These two studies were part of investigations aiming to 
establish if the FSDT could be of shorter duration when using the stickleback based on previous 
information that sexual differentiation in this species is completed by 42dph [Hahlbeck et al. 2004a] 
Two negative studies were performed: One with ammonium in zebrafish and one with n-octanol in 
Japanese medaka. No effect on sex ratios was seen in the experiments. 
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Kidney epithelium height (KEH) 
The measurement of the height of the stickleback kidney epithelium is a qualitative measurement of the 
androgen related spiggin induction that should respond to androgens by an increase. It is not a mandatory 
endpoint in the FSDT. The KEH was analysed in the four experiments conducted in Lab 6: In the 
experiment with 4-tert octylphenol an increase in KEH was observed for all exposure concentrations. This 
effect cannot be explained by an androgen mode of action but might indicate some kind of toxic effect of 
4-tert octylphenol on the kidneys. In the DHT experiment, an increase was observed at the highest 
exposure concentration of 739 ng/l. This would be expected to be an androgenic induction. An increase in 
KEH was also observed after E2 exposure at all concentrations in both males and females. Again this 
effect cannot be explained by an androgenic effect. No change in KEH was observed after exposure to the 
anti-androgenic flutamide.  
Summary of Phase-1 and Phase-2 validation results 
The present validation work is a good example of the importance of analysing the chemical concentrations 
in the water in aquatic exposure systems regularly. Several of the participating laboratories had difficulties 
with the acceptability criteria of a maximum deviation of ± 20% of the mean measured concentration. This 
is not a FSDT specific problem and it should be seen in the context of the diversity of the participating 
laboratories. Many are university laboratories not used to standardised test protocols. The use of contract- 
and industrial laboratories would for sure eliminate many of these problems. 
The two core endocrine endpoints in the FSDT are sex ratio and vitellogenin concentrations. As described 
earlier they should be validated in combination because this can give a picture of the MOA of the test 
substance. It is therefore important that the two endpoints have approximately the same sensitivity to the 
exposure chemicals. The sensitivity of the endpoints is indeed comparable, which can be seen from Table 
12 and 13. For example the mean VTG NOEC from three zebrafish 4-tert-octylphenol experiments is 13.6 
µg/l and the corresponding mean sex ratio NOEC is 9.7 µg/l. The corresponding NOECs for medaka are 
16.7 µg/l and 15.6 µg/l. For some modes of action as for example strong androgens the skewing of sex 
toward males is so strong the female VTG measurement is based on very few individuals and therefore not 
always useful. But in these cases the sex ratio response is sufficient for a risk or hazard assessment of the 
substance because a “no female” population is achieved. 
The validation of zebrafish, Japanese medaka and fathead minnow has identified equally sensitivity to the 
test substances regardless the strain or population used. A test with an androgen is needed in fathead 
minnow to complete the validation of this species. The three-spined stickleback showed comparable 
sensitivity to the zebrafish and the medaka by means of effects on VTG concentrations. However, it was 
proved less sensitive to phenotypic sex reversal caused by the present exposure chemicals compared to 
zebrafish and Japanese medaka. In the majority of cases the chemicals did have an effect on stickleback 
sexual differentiation but this was more by means of inducing a low incidence of intersex rather than 
causing a dramatic effect in the sex ratio. The reason might be a stronger genetic sex determination 
mechanism in comparison to the other test species. 
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APPENDIX 
Figures from the FSDT Phase 2 validation 
Schematic overview 
Table 33: Overview of the Annex 1 figures 
Exposure chemical endpoint species LAB Figure 
4-tert-octylphenol vitellogenin Zebrafish 1 Figure 3 
4-tert-octylphenol vitellogenin Zebrafish 2 Figure 4 
4-tert-octylphenol vitellogenin Zebrafish 4 Figure 5 
4-tert-octylphenol vitellogenin Japanese medaka 4 Figure 6 
4-tert-octylphenol vitellogenin Japanese medaka 5 Figure 7 
4-tert-octylphenol vitellogenin Japanese medaka 9 Figure 8 
4-tert-octylphenol vitellogenin Three spined stickleback 6 Figure 9 
4-tert-octylphenol vitellogenin Three spined stickleback 8 Figure 10 
Dihydrotestosterone vitellogenin Zebrafish 1 Figure 11 
Dihydrotestosterone vitellogenin Zebrafish 2 Figure 12 
Dihydrotestosterone vitellogenin Zebrafish 3 Figure 13 
Dihydrotestosterone vitellogenin Japanese medaka 5 Figure 14 
Dihydrotestosterone vitellogenin Japanese medaka 9 Figure 15 
Dihydrotestosterone vitellogenin Three spined stickleback 6 Figure 16 
Dihydrotestosterone vitellogenin Three spined stickleback 8 Figure 17 
4-tert-pentylphenol vitellogenin Japanese medaka 9 Figure 18 
4-tert-pentylphenol vitellogenin Japanese medaka 10 Figure 19 
17ß-estradiol vitellogenin Three spined stickleback 6 Figure 20 
flutamide vitellogenin Three spined stickleback 6 Figure 21 
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ammonium vitellogenin zebrafish 1 Figure 22 
n-octanol vitellogenin Japanese medaka 9 Figure 23 
4-tert-octylphenol sex ratio Zebrafish 1 Figure 24 
4-tert-octylphenol sex ratio Zebrafish 2 Figure 25 
4-tert-octylphenol sex ratio Zebrafish 4 Figure 26 
4-tert-octylphenol sex ratio Japanese medaka 4 Figure 27 
4-tert-octylphenol sex ratio Japanese medaka 5 Figure 28 
4-tert-octylphenol sex ratio Japanese medaka 9 Figure 29 
4-tert-octylphenol sex ratio Three spined stickleback 6 Figure 30 
4-tert-octylphenol sex ratio Three spined stickleback 8 Figure 31 
Dihydrotestosterone sex ratio Zebrafish 1 Figure 32 
Dihydrotestosterone sex ratio Zebrafish 2 Figure 33 
Dihydrotestosterone sex ratio Zebrafish 3 Figure 34 
Dihydrotestosterone sex ratio Japanese medaka 5 Figure 35 
Dihydrotestosterone sex ratio Japanese medaka 9 Figure 36 
Dihydrotestosterone sex ratio Three spined stickleback 6 Figure 37 
Dihydrotestosterone sex ratio Three spined stickleback 8 Figure 38 
4-tert-pentylphenol sex ratio Japanese medaka 9 Figure 39 
4-tert-pentylphenol sex ratio Japanese medaka 10 Figure 40 
17ß-estradiol sex ratio Three spined stickleback 6 Figure 41 
flutamide sex ratio Three spined stickleback 6 Figure 42 
Ammonia sex ratio zebrafish 1 Figure 43 
n-octanol sex ratio Japanese medaka 9 Figure 44 
4-tert-octylphenol KEH Three spined stickleback 6 Figure 45 
Dihydrotestosterone KEH Three spined stickleback 6 Figure 46 
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17ß-estradiol KEH Three spined stickleback 6 Figure 47 
flutamide KEH Three spined stickleback 6 Figure 48 
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Undifferentiated zebrafish, VTG
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Figure 3: Vitellogenin concentrations in female (A), male (B) and undifferentiated (C) zebrafish after 60 D 
exposure to 4-tert-octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control   
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Male zebrafish,VTG
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Figure 4: Vitellogenin concentrations in female (A), male (B) and undifferentiated (C) zebrafish after 60 D 
exposure to 4-tert-octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control     
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Male zebrafish, VTG
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Undifferentiated zebrafish, VTG
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Intersex zebrafish, VTG
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Figure 5: Vitellogenin concentrations in female (A), male (B), undifferentiated (C) and intersex (D) zebrafish 
after 60 D exposure to 4-tert-octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from 
control.  (*)=Significant different from control using 1-sided hypothesis testing.       
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Figure 6: Vitellogenin concentrations in female (A) medaka after 60 D exposure to 4-tert-octylphenol. 
Numbers at the bottom are N. P=0.05 . *=Significant different from control 
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Male medaka, VTG
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undifferentiated medaka, VTG
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Figure 7: Vitellogenin concentrations in female (A) and male (B) medaka after 60 D exposure to 4-tert-
octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control. (*)=Significant 
different from control using 1-sided hypothesis testing.    
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Genetic females Vs sex reversed males, VTG
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Figure 8: Vitellogenin concentrations in female (A), male (B) and genetic females versus sex reversed males (C) 
medaka after 60 D exposure to 4-tert-octylphenol. Numbers at the bottom are N. P=0.05. *=Significant 
different from control   
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Male three spined stickleback, VTG
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Figure 9: Vitellogenin concentrations in female (A) and male (B) stickleback after 60 D exposure to 4-tert-
octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control   
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Lab 8 
Female three spined stickleback, VTG
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Male three spined stickleback, VTG
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Figure 10: Vitellogenin concentrations in female (A) and male (B) stickleback after 60 D exposure to 4-tert-
octylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control   
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Male zebrafish, VTG
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Figure 11: Vitellogenin concentrations in female (A) and male (B) zebrafish after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control     
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Figure 12: Vitellogenin concentrations in female (A) and male (B) zebrafish after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control     
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Figure 13: Vitellogenin concentrations in female (A) and male (B) zebrafish after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control. 
(*)=Significant different from control using 1-sided hypothesis testing.    
     
Japanese medaka 
Lab 5 
Female medaka, VTG
LAB 5: DHT
con
trol
s
48.
8 n
g/l
155
 ng
/l
ng
 v
ite
llo
ge
ni
n/
g 
liv
er
1e+1
1e+2
1e+3
1e+4
1e+5
1e+6
2235
A
4
*
 
Male medaka, VTG
LAB 5: DHT
con
tro
ls
48.
8 n
g/l
155
 ng
/l
711
 ng
/l 
ng
 v
ite
llo
ge
ni
n/
g 
liv
er
10
100
1000
10000
44 7138
B
64
 
 
Undifferentiated medaka, VTG
LAB 5: DHT
con
tro
l
48.
8 n
g/l
155
 ng
/l
711
 ng
/l
ng
 v
ite
llo
ge
ni
n/
g 
liv
er
100
1000
4 6 0 3
C
 
 
Figure 14: Vitellogenin concentrations in female (A) and male (B) medaka after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control       
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Figure 15: Vitellogenin concentrations in female (A) and male (B) medaka after 60 D exposure to 
dihydrotestosterone. Percentage sex reversal (C) and vitellogenin of sex reversed fish (D). Numbers at the 
bottom are N. P=0.05. *=Significant different from control       
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Figure 16: Vitellogenin concentrations in female (A) and male (B) stickleback after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control       
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Figure 17: Vitellogenin concentrations in female (A) and male (B) stickleback after 60 D exposure to 
dihydrotestosterone. Numbers at the bottom are N. P=0.05. *=Significant different from control       
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Figure 18: Vitellogenin concentrations in female (A) and male (B) medaka after 70 D exposure to 4-tert-
pentylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control         
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Figure 19: Vitellogenin concentrations in female (A) and male (B) medaka after 60 D exposure to 4-tert-
pentylphenol. Numbers at the bottom are N. P=0.05. *=Significant different from control         
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Figure 20: Vitellogenin concentrations in female (A) and undifferentiated (B) stickleback after 37 D exposure 
to 17ß-estradiol. Numbers at the bottom are N. P=0.05. *=Significant different from control         
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Figure 21: Vitellogenin concentrations in female (A) and undifferentiated (B) stickleback after 41 D exposure 
to flutamide. Numbers at the bottom are N. P=0.05. *=Significant different from control. (*)=Significant 
different from control using 1-sided hypothesis testing.  
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Figure 22: Vitellogenin concentrations in female (a) and male (B) zebrafish after 60 D exposure to ammonium. 
Numbers at the bottom are N. P=0.05.  *=Significant different from control. 
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Figure 23: Vitellogenin concentrations in female (A) and male (B) Japanese medaka after 60 D exposure to n-
octanol. Numbers at the bottom are N. P=0.05. *=Significant different from control. 
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SEX RATIO AND GENETIC SEX 
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Figure 24: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to 4-tert-octylphenol. Numbers at bottom are N. P=0.05 
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Figure 25: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to 4-tert-octylphenol. Numbers at bottom are N. P=0.05 
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Figure 26: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to 4-tert-octylphenol. Numbers at bottom are N. P=0.05 
Japanese medaka 
Lab 4 
 
Medaka, sex ratio
%
0
20
40
60
80
100
Female 
Male 
intersex 
Undifferentiated 
Co
ntr
ol
11.
2 µ
g/l 
54 31 28 46
LAB 4, 4-tert octylphenol
* * *
104
.7 µ
g/l 
31.
7 µ
g/l 
*
*
*
*
 
Figure 27: Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D exposure to 
4-tert-octylphenol. Numbers at bottom are N. P=0.05 
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Figure 28: Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D exposure to 
4-tert-octylphenol. Numbers at bottom are N. P=0.05. (*)=one-sided test. 
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Figure 29: (A) Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D 
exposure to 4-tert-octylphenol. Numbers at bottom are N. P=0.05. (B) Percentage sex reversed males of total 
number of genetic males. 
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Figure 30: Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 60 D 
exposure to 4-tert-octylphenol. Numbers at bottom are N. P=0.05 
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Figure 31: Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 60 D 
exposure to 4-tert-octylphenol. Numbers at bottom are N. P=0.05 
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Figure 32: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to dihydrotestosterone. Numbers at bottom are N. P=0.05 
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Figure 33: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to dihydrotestosterone. Numbers at bottom are N. P=0.05 
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Figure 34: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to dihydrotestosterone. Numbers at bottom are N. P=0.05 
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Figure 35: Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D exposure to 
dihydrotestosterone. Numbers at bottom are N. P=0.05 
 ENV/JM/MONO(2011)23 
 
 77
Lab 9 
Medaka, sex ratio
%
0
20
40
60
80
100
Female 
Male 
intersex 
Undifferentiated 
Co
ntr
ol
94 
ng/
l
315
 ng
/l
100
4 n
g/l
70 59 66 58
LAB 9, dihydrotestosterone
*
 
Medaka, genetic females reversed to males
LAB 9: dihydrotestosterone
con
tro
l
94 
ng/
l 
315
 ng
/l 
100
4 n
g/l 
%
 s
ex
 re
ve
rs
al
 (f
em
al
e 
to
 m
al
e)
 
0
20
40
60
80
100
34 35 30 29
B
 
Figure 36: (A) Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D 
exposure to dihydrotestosterone. Numbers at bottom are N. P=0.05. (B) Percentage sex reversed females of 
total number of genetic females. 
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Figure 37: Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 60 D 
exposure to dihydrotestosterone. Numbers at bottom are N. P=0.05 
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Figure 38: Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 60 D 
exposure to dihydrotestosterone. Numbers at bottom are N. P=0.05 
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Figure 39: (A) Sex ratio as percentage females, males, undifferentiated and intersex medaka after 70 D 
exposure to 4-tert-pentylphenol. Numbers at bottom are N. Asterisk in brackets: Genetic males changed to 
phenotypic females. P=0.05. (B) Percentage sex reversed males of total number of genetic males. 
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Figure 40: Sex ratio as percentage females, males, undifferentiated and intersex medaka after 60 D exposure to 
4-tert-pentylphenol. Numbers at bottom are N. P=0.05 
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Figure 41: (A) Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 42 D 
exposure to 17ß-estradiol. Numbers at bottom are N. P=0.05. (B) Percentage sex reversed males of total 
number of genetic males. 
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Figure 42: Sex ratio as percentage females, males, undifferentiated and intersex stickleback after 42 D 
exposure to flutamide. Numbers at bottom are N. P=0.05 
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Figure 43: Sex ratio as percentage females, males, undifferentiated and intersex zebrafish after 60 D exposure 
to ammonium. Numbers at bottom are N. P=0.05 
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Figure 44: Sex ratio as percentage females, males and sex reversed males. Japanese medaka after 60 D 
exposure to n-octanol. Numbers at bottom are N. P=0.05 
KIDNEY EPITHELIUM HEIGHT (KEH) 
The measurement of the stickleback KEH is a qualitative measurement of the androgen related spiggin 
induction. It is not a mandatory endpoint in the FSDT. 
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Figure 45: Kidney epithelium height (KEH) in mm after 60 D exposure to 4-tert-octylphenol of female (A) and 
male (B) stickleback. Numbers at bottom are N. P=0.05 
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Figure 46: Kidney epithelium height (KEH) in mm after 60 D exposure to dihydrotestosterone of female (A) 
and male (B) stickleback. Numbers at bottom are N. P=0.05 
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Figure 47: Kidney epithelium height (KEH) in mm after 42 D exposure to 17ß-estradiol of female (A) and 
undifferentiated (B) stickleback. Numbers at bottom are N. P=0.05  
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Figure 48: Kidney epithelium height (KEH) in mm after 42 D exposure to flutamide of female (A) and 
undifferentiated (B) stickleback. Numbers at bottom are N. P=0.05 
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